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1 Summary 
Stem cells are a key requisite for multi cellular organisms. In multi cellular organisms 
different stem cell populations create a diversity of specialized cells during 
development and persist throughout adulthood. The key features of stem cells are 
their self-renewal capacity and the potential to differentiate into many cell types. 
Extensive research is in progress to understand the intrinsic and extrinsic factors 
that regulate the self-renewal behavior and fate restrictions of stem cells.  
Neural crest stem cells are a transient population during development that 
delaminate from the tip of the dorsal tube during its closure, migrate throughout the 
body to distinct locations and differentiate into a variety of different cell types. Neural 
crest cells build up glial and neuronal cells of the peripheral nervous system, 
melanocytes, chondrocytes and osteocytes. Since the fate acquisition of neural 
crest cells is dependent on their level of emigration from the neural tube, comprising 
cranial neural crest cells in anterior regions of the embryo and trunk neural crest 
cells from more posterior locations, these different fate acquisitions have to be 
differentially regulated. The capability of cranial neural crest cells to build up the 
chondro- and skeletogenic elements of the craniofacial regions evolved in 
gnathostomata and allowed a predatory lifestyle due to the development of jaws. 
This thesis investigates the role of enhancer of zeste homolog 2, a polycomb 
repressive complex 2 member in neural crest development. Interestingly, it became 
apparent that cranial neural crest cells are dependent on enhancer of zeste 
homolog-2, rather than trunk neural crest cells. The differentiation of trunk neural 
crest cells in neural derivatives is not impaired, whereas the differentiation of cranial 
neural crest cells in mesenchymal derivatives is blocked. The blockage of 
craniofacial chondro- and skeletogenesis comes from the de-repression of Hox 
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genes in NCCs. In mammals that evolved a neural crest, enhancer of zeste 
homolog-2 regulates additionally and later in development the repression of Hox 
genes that otherwise would block chondro- and skeletogenesis. Therefore we 
observe upon conditional deletion of enhancer of zeste homolog-2 the complete loss 
of cranial neural crest derived craniofacial structures. 
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2 Zusammenfassung 
Stammzellen sind eine Vorraussetzung für die Entstehung von Mehrzellern. 
Verschiedene Stammzellpopulationen generieren die Vielzahl spezialisierter Zellen 
während der Entwicklung von Mehrzellern und selbst in adulten Lebewesen sind 
noch Stammzellpopulationen zu finden. 2 Schlüsselelemente von Stammzellen sind 
die Möglichkeit zur Selbsterneuerung und das Potential in verschiedene Zelltypen 
zu differenzieren. Viel Forschungsaufwand wird betrieben um die intrinsichen und 
extrinischen Faktoren, die das Selbsterneurungspotential und die Multipotentialität 
regulieren, zu verstehen.  
Neuralleistenstammzellen sind eine während der Entwicklung vorübergehend 
vorkommende Population von Stammzellen. Diese Neuralleistenstammzellen 
emigrieren von der dorsalen Seite des Neuralrohrs, während es sich in der 
Entwicklung schliesst. Sie wandern auf festen Routen durch den Embryo und 
differenzieren an spezifischen Zielorten in verschiedene Zelltypen. Die 
Neurallleistenzellen bilden die neuronalen und glialen Zellen des peripharen 
Nervensystems, sie differenzieren in Pigmentzellen der Haut, Knorpel- und 
Knochenzellen. In welchen Zelltypus die Neuralleistenzellen differenzieren ist 
abhängig von dem Ort von dem sie aus dem Neuralrohr emigrieren. Craniale 
Neuralleistenzellen emigrieren von vorderen  Positionen im Embryos aus, wogegen 
Rumpfneuralleistenzellen eher aus den caudalen Regionen emigrieren. Das 
Potential der cranialen Neuralleistenzellen Knorpel und Knochen des Kopfes 
aufzubauen entwickelte sich evolutiv in Gnathostomen und erlaubte es diesen durch 
die Entwicklung eines Kiefers einen predatorischen Lebensstil anzunehmen.  
Diese Arbeit untersucht die Rolle von „Enhancer of zeste homolog-2“, einem Faktor 
der im „Polycomb repressive complex 2“ integriert ist, in der 
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Neuralleistenentwicklung. Interessanterweise wurde klar, dass die cranialen 
Neurallleistenzellen auf Enhancer of zeste homolog-2 angewiesen sind, wogegen 
die Rumpfneuralleisten nicht affektiert waren. Die Differenzierung der 
Rumpfneurallleistenzellen in neurale Derivate ist nicht beeinträchtigt, allerdings ist 
die Differenzierung der cranialen Neuralleistenzellen in die mesenchymalen 
Derivate blockiert. Diese Blockierung rührt von der Üeberexprimierung von Hox-
Genen in Neuralleistenzellen. In Säugetieren reprimiert enhancer of zeste homolog-
2 zusätzlich und später in der Entwicklung die Hox Gene, was sonst eine 
Blockierung der Neuralleistenzellen Differenzierung in die skeletalen Elemente des 
Kopfes zur Folge hätte. Deswegen sehen wir, aufgrund der konditionellen Deletion 
von enhancer of zeste homolog-2 in Neuralleistenzellen, das völlige Fehlen der 
Knorpel und Knochenstrukturen im Schädel, die normalerweise von cranialen 
Neuralleistenzellen aufgebaut werden. 
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3 Introduction 
  
3.1 The neural crest 
The “neural crest” (NC) was first described by the Swiss Histologist His in 1868 who 
described a layer of cells between neural ectoderm and non-neural ectoderm as 
“Zwischenstrang” meaning “in-between-strip” or intermediate cord. More recently, it 
has already been proposed to call the NC the fourth germ layer, along with 
endoderm, mesoderm and ectoderm due to the broad potential of neural crest cells 
(NCC) (Hall 1998; Hall 2000). NCCs get specified in the neural tube and undergo an 
epithelial to mesenchymal transition to become migratory. The process of emigration 
of NCCs follows the rostral caudal gradient of neural tube closure during 
neurulation. After epithelial to mesenchymal transition, NCCs migrate via distinct 
pathways to their target sites and differentiate into a plethora of cell types. They give 
rise to neurons and glia cells of the peripheral nervous system, pigment cells of the 
skin (melanocytes) and cartilage and bone of the head. All these processes are 
tightly controlled and regulated by extracellular growth factors, intracellular signaling 
cascades, transcription factor activation/repression and epigenetic modulations 
(Knecht and Bronner-Fraser 2002; Gammill and Bronner-Fraser 2003; Crane and 
Trainor 2006; Dupin, Creuzet et al. 2006; Prasad, Sauka-Spengler et al. 2012). The 
NC is a vertebrate invention; therefore organisms like worms or flies lack it. In 
phylogenetic groups closer to vertebrates, cephalochordate (e.g. amphiouxus) and 
even vertebrates, like agnatha (e.g. lamprey) start to express NC specifier and 
regulatory genes and agnatha already have migratory NCCs, but they lack a jaw. 
But these species partially have already the regulatory elements and gene 
expression patterns that later on will become important for NC development (like 
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homeobox containing (Hox) genes and nested distal-less (Dlx) expression). The 
gnathostomes (including e.g. fish, chick and mouse) are the first jawed organisms to 
appear in evolution. And jaw development was a critical switch in lifestyle, since 
these organisms became active predators, what facilitated vertebrate radiation into 
new environments. On the cellular level important changes are the repression of 
mandibular and maxilliary Hox gene expression and the occurrence of nested Dlx 
expression, which allowed craniofacial evolution and ossification of facial elements. 
The regulatory elements that regulate and fine-tune jaw development were partially 
duplicated from pre-existing regulatory elements and/or required additional 
regulatory mechanisms (Gans and Northcutt 1983; Trainor, Melton et al. 2003; Hall 
and Gillis 2012). 
 
 
Figure 1: Appearence of the neural crest in evolution  
Already cephalochordates show expression of Snail, Hox and Dlx genes but lack a 
migratory neural crest. Agnathans have a migratory neural crest, but show Hox 
expression in mandible, naming them jawless vertebrates. The gnathostomes 
developed a migratory neural crest and the loss of Hox expression in the mandible 
allowed the development of jaws. Adapted from Trainor, 2003. 
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3.1.1 Neural crest induction  
NCCs get induced at the border of neural and non-neural ectoderm therefore NCCs 
can be seen as a third layer of ectodermal cells and sometimes even seen as fourth 
germ layer (Mayor and Aybar 2001). Bone morphogenic protein (BMP) is expressed 
throughout the ectoderm during gastrulation and suppresses neural fates. Therefore 
BMP antagonists, like chordin or noggin have to block BMP activity in presumptive 
neural tissue (Wilson and HemmatiBrivanlou 1997). Additional morphogens that are 
involved in neural plate border induction are fibroblast growth factors (FGF) and 
Wnts. FGF signaling can act in chicken as a neural inducer and is required for 
neural induction (Streit, Berliner et al. 2000; Knecht and Bronner-Fraser 2002). 
Further, FGF signaling from the paraxial mesoderm plays a critical role for neural 
plate border induction, since FGFs are capable to induce a subset of neural crest 
markers (Monsoro-Burq, Fletcher et al. 2003). Wnt proteins are expressed from non-
neural ectoderm at the correct time and are neural plate border specifiers, too 
(Garcia-Castro, Marcelle et al. 2002). These early events of neural plate border 
specification from inductive signals, like BMPs, FGFs and Wnts activate a gene 
regulatory network in neural plate border cells, comprising transcriptional regulators 
and downstream effectors that cooperatively and sequentially provide NC identity. 
Neural plate border specifier genes that get upregulated, including Msx1/2, Pax3/7 
and Zic, enable NCCs to express neural crest specifier genes, like AP-2, FoxD3, 
Sox9, Snail1/2 (Sauka-Spengler and Bronner-Fraser 2008; Bronner 2012; Prasad, 
Sauka-Spengler et al. 2012). Some functions of these genes remain elusive but for 
example, Snail1/Snail2 expression represses E-cadherin to break up the adherent 
and tight junctions, conferring the ability to migrate to NCCs (Nieto, Sargent et al. 
1994; Carl, Dufton et al. 1999; LaBonne and Bronner-Fraser 2000). Another factor 
for NC specification is FoxD3. In mice it was shown that FoxD3 maintains self-
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renewal and multipotentiality in NCCs (Mundell and Labosky 2011). An additional 
function of FoxD3 might be of more general nature. FoxD3 is considered to open 
chromatin and potentiating gene transcription as it was shown for a related protein, 
namely FoxA (Cirillo, Lin et al. 2002). With these gene expression changes NCCs 
become capable to undergo epithelial to mesenchymal transition, delaminate from 
the dorsal tip of the neural tube and start migrating. Migratory NCCs start to express 
the transcription factor Sox10 and the low affinity receptor p75 (Stemple and 
Anderson 1992; Kapur 1999; Paratore, Goerich et al. 2001; Kim, Lo et al. 2003).  
 
 
Figure 2: Neural induction 
and emigration of neural 
crest cells 
Neural crest cells get specified 
in the neural plate border 
during neurulation (green 
area). Surrounding tissue like, 
neural ectoderm, non-neural 
ectoderm and paraxial 
mesoderm secrete factors that 
specify neural crest cells. After 
closure of the neural tube 
neural crest cells undergo an 
epithelial- mesenchymal 
transition and become 
migratory. Adapted from 
Gammil and Bronner-Fraser, 
2003. 
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3.1.2 Neural crest stem cells 
Multipotency and self-renewal capacity are two criteria to define stem cells. 
Multipotency refers to the fact that a stem cell can give rise to different cell types 
and self-renewal capacity means the ability to produce a stem cell during cell 
division (Crane and Trainor 2006). A controversial discussion in the field is the 
existence of neural crest stem cells (NCSC). Two models are facing each other, 
both experimentally supported, namely the model describing a multipotent NCSC 
emigrating and getting fated mainly via environmental signals at target locations. On 
the other hand the model of pre-specification in the neural tube, showing that the 
location and time-point of neural crest specification in the neural tube determines the 
fate of the NCC. The already mentioned criteria for stem cells, like multipotentiality 
and self-renewal capacity was shown for NCSCs in vitro (Sieber-Blum and Cohen 
1980; Stemple and Anderson 1992; Kleber, Lee et al. 2005). In vivo analysis of 
NCCs in avian embryos supported the hypothesis of multipotentiality, since single, 
dye labeled cells, were found in many derivatives build up by the NC, like neurons, 
glia or melanocytes (Bronner-Fraser and Fraser 1988; Bronner-Fraser and Fraser 
1991). Another report showed the quantity of multipotent NCCs in quail neural crest, 
therefore supporting the NCSC hypothesis again (Trentin, Glavieux-Pardanaud et al. 
2004).  On the other side is the model of pre-specification in the neural tube, 
showing that the location and time-point of neural crest specification in the neural 
tube determines the fate of the NCCs. The pre-specification theory supported by 
experiments done by Krispin and collegues in chicken via single cell labeling in vivo. 
It was proposed that pre-specification in the neural tube determines the fate of 
NCCs building up distinct derivatives just in a temporal manner, via migrating dorso-
ventrally for neural derivatives and dorso-laterally for non-neural tissues, like 
melanocytes (Krispin, Nitzan et al. 2010).  
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NCSC-like cells can even be isolated from post-migratory targets of NCCs. Studies 
isolating cells from sciatic nerves, dorsal root ganglia (DRG), gut or skin found cells 
that resemble NCSCs (Morrison, White et al. 1999; Bixby, Kruger et al. 2002; 
Delfino-Machin, Chipperfield et al. 2007). But post-migratory NCSCs have to adapt 
to their new environment, resulting in a change of growth factor requirement and/or 
receptor expression or changes in division mode (White, Morrison et al. 2001; Falk 
and Sommer 2009; Fuchs, Herzog et al. 2009). And there are reports claiming that 
NCSC-like cells can be even isolated from adult tissues, like bone marrow or skin 
(Wong, Paratore et al. 2006; Nagoshi, Shibata et al. 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Features of stem cells 
The two main features of stem cells. Self-renewal generates two identical daughter 
cells and multipotentiality refers to the potential of stem cells to differentiate into 
multiple and different cell types. 
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3.1.3 Instructive factors for NC fates 
In vitro and in vivo studies revealed several molecules that act on NCSCs and 
promote differentiation. These environmental signals are of instructive nature, 
directly promoting certain fates. Transforming growth factor-beta (Tgf-β) promotes a 
mesenchymal cell fate of NCCs in vitro, mediating the switch of NCSCs to 
mesenchymal progenitor cells (MPC) that populate the branchial arches (BA) (Shah, 
Groves et al. 1996; John, Cinelli et al. 2011). In vivo Tgf-β receptor ablation in NCCs 
causes cleft palate and calvarias defect, additionally it regulates self-renewal of 
midbrain neural stem cells (Ito, Yeo et al. 2003; Falk, Wurdak et al. 2008). When 
Tgf-β is conditionally ablated in NCCs the defects of DiGeorge syndrome is 
resembled in mice (Wurdak, Ittner et al. 2005). This indicates an instructive role for 
Tgf-β signaling in NCCs for adoption of mesenchymal fates. Another report shows 
the need of NCCs for BMP2 to differentiate into autonomic neurons (Morrison, White 
et al. 1999). BMPs belong to the Tgf-β superfamily, showing another role for these 
molecules in NC development. Depending on the context, members of the Tgf-β 
superfamily promote different cell fates and can even lead to apoptosis (Hagedorn, 
Suter et al. 1999). The complexity and redundancy of the system in vivo is 
exemplified by work of Buchmann-Moller and colleagues who showed that 
conditional ablation of Smad4, a downstream  target of canonical BMP signaling,  in 
NCCs doesn’t lead to neuronal or smooth muscle defects (Buchmann-Moller, 
Miescher et al. 2009). The glial lineage of NCCs can be promoted with neuregulins 
(Shah, Marchionni et al. 1994; Jessen and Mirsky 2005). A factor exemplifying the 
context and time dependent need and function of growth factors, is Wnt1. Already 
described as a molecule needed for neural plate border induction it has additional 
roles in NC development at later time points. In vitro cultures of NCSCs instructed 
with Wnt1 adopt a sensory neuronal fate. In vivo overexpression of β-catenin, a 
downstream effector of Wnt signaling, results in sensory neurogenesis to the 
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expense of other lineages (Hari, Brault et al. 2002; Lee, Kleber et al. 2004). Further, 
in vivo ablation of β-catenin, results in loss of melanocytes in mice (Hari, Brault et al. 
2002). Therefore, Wnt/β-catenin signaling is needed at two different time points 
during NC development and has distinct functions (Hari, Miescher et al. 2012). An 
overview of different instructive growth factors for NCSCs and they cellular fate is 
given in Figure 4. 
 
  
Figure 4: Instructive growth factors for neural crest cell differentiation 
With an in vitro culture system for neural crest stem cells it became possible to 
screen for instructive growth factors. This led to the identification of several 
instructive growth promoting different fates of neural crest stem cells. 
Adapted from Shakhova and Sommer, 2010. 
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3.1.4 Subpopulations of NCCs 
NCC emigration occurs along the neural tube during its closure. Dependent on the 
rostral-caudal level of emigration, NCCs can be divided into subpopulations. The 
level of emigration restricts the potential of NCC subpopulations in vivo. Cranial 
neural crest cells (CNCC) emigrate from mid-diencephalic level caudal to somite 4 
(rhombomere 7). They have the broadest potential, differentiating into chondrocytes, 
osteoblasts, neurons, glia cells and melanocytes. CNCCs build up the cranial 
nerves, melanocytes of the later head region and differentiate into chondrocytes and 
osteocytes of the facial area. Some bones of the skull are exclusively built up by 
CNCCs, to others they just contribute. Preliminary structures to the craniofacial 
derivatives of NCCs are the BAs. Getting established and populated by NCCs from 
E9.5 onwards, the BAs get remodeled around E12 into their later shape, like 
maxillary or mandible (Santagati and Rijli 2003; Le Douarin, Brito et al. 2007; John, 
Cinelli et al. 2011). Another NC subpopulation is the vagal NC. Emigrating NCCs 
from somites 1-7, therefore partially overlapping with emigration domains of CNCCs, 
build up the ENS. The colonization of the gut spans approximately from E9.5 to 
E15.5 establishing the plexus that innervates the gut (Heanue and Pachnis 2007). 
The cardiac NC, emigrating from the level of the otic placode caudal until somite 3, 
is part of the cranial neural crest. Emigration domains are completely overlapping 
with CNCCs. These NCCs build up the outflow tract of the heart, adopting a 
mesenchymal fate, too (Sieber-Blum 2004). Lastly, trunk NCCs, emigrate from 
somite 7 to most caudal regions give rise to the PNS. They build up structures, like 
DRGs, autonomic ganglia (AG), peripheral nerves, they populate the medulla of the 
adrenal gland and give rise to melanocytes (Le Douarin and Dupin 2012). Their 
fates are more restricted compared to CNCCs, even though they have skeletogenic 
potential in vitro, they don’t differentiate into osteocytes in vivo (McGonnell and 
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Graham 2002; John, Cinelli et al. 2011). Firstly, trunk NCCs differentiate into 
neurons including neuronal subtypes, like sensory neurons and autonomic neurons 
(Eng, Lanier et al. 2004; Howard 2005). Secondly, the glial lineage is represented by 
satellite cells and Schwann cells (Woodhoo and Sommer 2008). And lastly, they 
give rise to melanocytes in the skin (Thomas and Erickson 2008; Sommer 2011).  
 
 
 
 
 
 
 
Figure 5: Different levels of emigration for trunk NCCs and CNCCs and their
cellular fates 
Cranial neural crest cells emigrate from mid-diencephalic levels caudal to somite 4, 
(rhombomere 7) and these differentiate in to chondrogenic and smooth muscle cells 
additionally to the fates trunk neural crest cells aquire. Trunk neural crest cells 
emigrate from somite 7 to most caudal regions and mainly build up the peripheral 
nervous system (neurons and glia) and melanocytes. Adapted from Abzhanov et al., 
2003  
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3.1.4.1 Cranial neural crest  
CNCCs emigrate from the mid-diencephalic level caudal to somite 4 (rhombomere 
8) and they contribute to cartilage, bone and connective tissue, comprising 
additional cell fates in comparison to trunk NCCs (Santagati and Rijli 2003; Le 
Douarin, Brito et al. 2007). From rostral NCCs the frontonasal processes arise, 
whereas more posterior CNCCs, mainly emigrating from the rhombomeres of the 
hindbrain, go through an intermediate step of branchial arch (BA) population to build 
up cartilage and bone of jaw, middle or neck (Noden 1978; Couly, Coltey et al. 1993; 
Jiang, Iseki et al. 2002). CNCCs emigrate from domains including the hindbrain. The 
CNCCs emerging from these domains migrate and populate the BAs. BAs (BA1-
BA4) are transient structures during development, getting established in rostral-
caudal fashion from E9.5 onwards in mice and the cells get remodeled into terminal 
structures, like maxilliary or mandible around E12.0 onwards (Chai, Jiang et al. 
2000; Jiang, Iseki et al. 2002). The vertebrate hindbrain is patterned uniquely. It is 
segmented during development into 7 rhombomeres. This segmentation is achieved 
by a unique Hox gene expression code in the rhombomeres, providing spatial 
information for cranial ganglia or branchiomotor nerves (Trainor and Krumlauf 2001). 
A factor that establishes the early ‘Hox code’ for anterior-posterior patterning in the 
neural tube is e.g. retinoic acid (RA). Additional factors and more local ones are 
FGFs or Wnts (Studer, Gavalas et al. 1998; Gavalas and Krumlauf 2000; Irving and 
Mason 2000; Kiecker and Niehrs 2001). Additionally, the anterior-posterior 
segmentation of the hindbrain provides migratory information for CNCCs that 
emigrate from the hindbrain. 3 streams of CNCCs, adjacent to rhombomere2, 4 and 
6 can be observed, migrating to and populating BA1, 2 and 3, respectively (Couly 
and Ledouarin 1988; Serbedzija, Bronnerfraser et al. 1992). CNCCs transpose the 
Hox code they acquired from the neural tube to the BA mesenchyme (Trainor and 
Krumlauf 2001). This retained Hox gene expression provides anterior-posterior 
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positional information to the BA mesenchyme. Interestingly, the Hox gene 
expression can be adjusted. All CNCCs in BA1 and more rostral domains should be 
devoid of Hox gene expression to generate skeletal elements of the facial area. But 
the Hoxa2 expression domain reaches until the border of rhombomere 1 and 2. 
CNCCs that emigrate from rhombomere 2 express Hoxa2, therefore when they 
migrate into BA1 they have to silence Hoxa2 expression. Partially, anterior-posterior 
positional information, in the Hox free domains (BA1 and rostrally), is provided by 
another homeodomain containing factor, Otx2. Otx2 is expressed in midbrain 
derived CNCCs, and from these cells the distal mandibular and frontonasal skeletal 
elements arise, whereas the rhombomere derived Hox free BA1 cells  give rise to 
the proximal parts of these structures (Matsuo, Kuratani et al. 1995; Kuratani, 
Matsuo et al. 1997). A schematic that illustrates CNCC migration into the BAs (in the 
scheme named pharyngeal arch (PA)) and their respective Hox code is given in 
Figure 6. 
 
 
 
 
 
Figure 6: Origin of CNCCs and Hox gene expression in the BAs 
Cranial neural crest cells emigrate from the hinbrain which is segmented into 7 
rhombomers (r1 – r7). Cranial neural crest cells from r1, r2 and r3 migrate into 
pharyngeal arch 1 (PA1), part of the cells from r3, r4 and part of r5 migrate to PA2 
and cells from r5, r6 and r7 migrate into PA3 and PA4. In the arches cranial neural 
crest cells have a specific Hox gene expression pattern, having no Hox expression 
when populating PA1 and more rostral regions, Hoxa2 expression in PA2 and 
expressing a defined Hox gene code in PA3 and PA4. Adapted from Couly et al. 
2002 
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Further these cells have to get dorso-ventral positional information. Dlx5 and Dlx6 
are expressed along this axis in the BA mesenchyme. A knock-out of Dlx5 and Dlx6 
results in a homeotic transformation of the lower jaw into an upper jaw (Beverdam, 
Merlo et al. 2002; Depew, Lufkin et al. 2002; Jeong, Li et al. 2008). The tissue 
interaction of BA cells and the surrounding cells is another important factor for fate 
determination of these cells. Intrinsic properties of CNCCs, mediated by Tgf-β 
signaling that confers a switch from a Sox10-positiv NCSC to the Sox9-positiv, but 
Sox10-negativ, MPC. These MPCs populate the BAs and enable CNCCs to 
differentiate into the mesenchymal fates of the NC (John, Cinelli et al. 2011). Tgf-β 
receptor inactivation in NCCs leads to many defects including cleft palate defects 
(Wurdak, Ittner et al. 2005). BMP is another signaling molecule that confers 
specificity to structures derived from CNCCs. Concomitant application of noggin, a 
BMP antagonist, and retinoic acid transforms the maxillary into a supernumerary 
fronto-nasal plate (FNP) (Lee, Fu et al. 2001). Another expression source of BMPs 
is the BA ectoderm. BMP4 in the first place restricts the expression domain of FGF8 
in the ectoderm and acts synergistically with FGF8 on CNCCs (Mina, Wang et al. 
2002). Further, tissue interactions and signaling molecules are essential and 
sufficient. FGF8, for example, is expressed by the facial and branchial ectoderm. 
FGF8, together with BMP4, induce specific gene expression profiles and determines 
their rostral-caudal polarity in the BA1, but seems to be dispensable for survival of 
CNCCs in the BAs (Trumpp, Depew et al. 1999; Tucker, Yamada et al. 1999; 
Shigetani, Sugahara et al. 2002; Hu, Marcucio et al. 2003). Further studies on FGFs 
and their receptors revealed an important role for FGFs and their respective 
receptors in osteogenesis, like proliferation, differentiation and even in antagonizing 
other signaling molecules, like BMPs. FGF2 and FGF4 promote cartilage formation, 
whereas Fgfr2 regulates stem cell proliferation and Fgfr1 regulates osteogenic 
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differentiation (Richman, Herbert et al. 1997; Iseki, Wilkie et al. 1999; Sarkar, Petiot 
et al. 2001; Moore, Ferretti et al. 2002).  
All these interactions of intrinsic and extrinsic signals results in the generation of the 
facial skeleton. But even though CNCCs contribute to a large extend to the facial 
skeleton they are not the only source of cells building up the bones of the skull. 
Another source for cells of craniofacial bones is the cranial mesoderm. Vertebrate 
skulls are assembled by neurocranium (skull vault and base) and viscerocranium 
(jaws and other BA derivatives). The viscerocranium and the anterior neurocranium 
are exclusively CNC derived, whereas the posterior skull vault has mesodermal 
contributions or is of sole mesodermal origin for some bones (Jiang, Iseki et al. 
2002; Gross and Hanken 2008; Gitton, Heude et al. 2010). 
 
Figure 7: Neural crest derived skull bones 
The scheme shows the bones that are cranial neural crest derived (red and white) 
and which are cranial mesoderm derived (grey). To some bones cranial neural crest 
cells just contribute, e.g. the medial portion of the interparietal bone. Adapted from 
Jiang et al., 2002.  
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3.1.4.2 Trunk neural crest  
After emigration from the neural tube from the level of somite 7 to most caudal 
regions, trunk NCCs migrates in two distinct pathways. The dorso-ventral route and 
the dorso-lateral pathway (Kuriyama and Mayor 2008). NCCs migrating via the 
dorso-ventral pathway build up and differentiate into cells from the AG, DRG and 
when delaminating on a certain axial level of the embryo into chromaffin cells (…). 
NCCs migrate through the somatic mesoderm or a route between the neural tube 
and the somatic mesoderm and when migrating through the somite their way is 
restricted to the anterior somite. These pathway restrictions are mediated by 
guidance molecules, mainly comprising Ephrins/Ephrin receptors, 
Semaphorins/Neuropilin and Slit/Robo interactions (Kasemeier-Kulesa, Bradley et 
al. 2006). Ephrins have a bifunctional role. Early NC is repelled from the dorso-
lateral pathway, but at a later developmental stage Ephrins promote melanoblast 
migration along exactly that pathway (Santiago and Erickson 2002). Another 
suggested repellent for early NCCs to enter the dorso-lateral pathway is Slit2. Early 
NCCs express Robo1 and Robo2, suggesting a role of the Slit/Robo interaction on 
early NCCs migration (Jia, Cheng et al. 2005). Semaphorin 3F, a repulsive ligand, is 
expressed in the posterior half of each somite, directing NCCs that express the 
neuropilin2 receptor to migrate through the anterior part of the somite (Gammill, 
Gonzalez et al. 2006). After arriving at their target location, like AG or DRG, NCCs 
build up structures and differentiate into specific cell types of the respective 
structure. 
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3.2 Epigenetics 
The described features of stem cells are intrinsic and extrinsic properties to them. 
And all these processes underlie at least partially epigenetic regulation. Epigenetics 
as a term was defined in 1947 by Waddington. The definition underwent a few 
adjustments during time and is now considered to define all meiotically and 
mitotically inheritable changes in gene expression without changes in the underlying 
DNA sequence. Epigenetics include 3 major systems, DNA methylation, RNA 
interference and histone modifications (Egger, Liang et al. 2004). All three 
mechanisms together set up an epigenetic state that enables or disables 
transcription of genes in different regions of the genome.  
 
 
 
 
 
 
 
 
Figure 8: Epigenetic modes 
The 3 major epigenetic modes and their considered interactions between each other. 
All 3 modes result in a heritable gene silencing. Adapted from Egger et al., 2004 
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A first distinction of chromatin types can be made by histological examination, 
dividing the genome into euchromatin and heterochromatin. Whereas euchromatin 
is the sparsely packed chromatin, considered to harbor transcriptionally active 
genes, the heterochromatin is the densely packed chromatin, containing silent 
genomic regions (Gaspar-Maia, Alajem et al. 2011). The proportions of euchromatin 
and heterochromatin are changing during differentiation, with ESCs containing 
barely heterochromatin. As differentiation progresses the cells silence more and 
more genomic regions and increase with that the proportion of heterochromatin 
(Ahmed, Dehghani et al. 2010). Other reports showed the linkage of epigenetic 
marks to the sort of chromatin, e.g. are histone 3 lysine 9 (H3K9) and histone 3 
lysine 27 (H3K27) methylation rich on silent genes and therefore found in 
heterochromatin, opposed by histone 3 lysine 4 (H3K4) trimethylation standing for 
active genes present in euchromatin (Meshorer, Yellajoshula et al. 2006; Bhaumik, 
Smith et al. 2007; Hawkins, Hon et al. 2010). This reflects the intermingled functions 
of epigenetic modifications and the complexity of how gene transcription is regulated 
on a non DNA level.  
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3.2.1 Histone modifications 
A nucleosome is defined as a unit of 146bp of DNA wrapped around an octamer of 
dimers of histones H2A, H2B, H3 and H4. A linker region of DNA between two 
nucleosomes is associated with histone H1. A nucleosome is the repetitive, single 
unit that builds up chromatin. N-terminally, polypeptide chains extend from the 
histone core region. These histone tails are subject to posttranslational modifications 
(Olins and Olins 2003). Histone modifications include acetylation of lysines, 
methylation of arginines and lysines and phosphorylation of serines and threonines 
among others. Several modifications are present simultaneously on a histone tail 
and their overall presence influence higher order of chromatin or specifically 
modulate gene transcription (Berger 2007; Kouzarides 2007; Turner 2007).  
 
Figure 9: Histone modifications 
Schematics of possible modifications that can be placed on the histone tails. All 4 
histone proteins are subjects to modifications, like phosphorylation, acetylation 
methylation and ubiquitination. Adapted from Kouzardis et al., 2008 
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Just lysine residues of histones are acetylated and acetylation is correlated with 
transcriptional activity. The acetylation of lysine residues is thought to neutralize the 
positive charge of lysines, alters the histone-DNA interactions and with that opens 
the chromatin structure, making the DNA accessible for transcription factors. 
Acetylation and deacetylation of lysine residues, is catalyzed by histone acetyl 
transferases (HATs) and histone deacetylases (HDACs), respectively. Due to its 
ability to open chromatin many transcriptional complexes, like p300/CBP or 
NCoR/SMRT have acetylation or deacetylation activity, dependent on their own 
function on transcription (Shahbazian and Grunstein 2007). 
A prominent example for histone phosphorylation is the phosphorylation of serine 10 
or 28 on H3. The serine residues get phosphorylated just during M-Phase of the cell 
cycle and serve as a read-out for mitotically active cells in M-phase. The 
phosphorylation id mediated by the Aurora kinases. An advantage is that PHH3 
positive cells are easily distinguishable from apoptotic cells. Immunohistochemistry 
with PHH3 antibodies is already used in clinics due to its specificity and even fulfills 
WHO standards (Ribalta, McCutcheon et al. 2004). But other amino acid residues 
are also phosphorylated during cell cycle, like H2A serine 1, too (Barber, Turner et 
al. 2004).  
Histone methylation was found on arginines and lysines of histones 3 and 4. For 
histone lysine methylation, just found on amino acid residues of H3 and H4, six 
lysines are targets of methylation. Lysine 4, 9, 27, 36 and 79 of histone 3 and lysine 
20 of histone 4 can be mono-, di- or trimethylated.  Contrary to acetylation, lysine 
methylation can be either an activating or repressing signal, depending on the lysine 
residue that gets modified. Whereas H3K4me3, H3K36me3 and H3K79me3 are 
active marks, the methylation of the other lysine residues would result in a 
transcriptional repression. The arginine’s 2, 8, 17 and 26 of H3 or arginine 3 of H4 
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can just be mono- or dimethylated and the transcriptional outcome depends on the 
methylated residue, as well. Enzymes of the PRMT and CARM members are the 
known methyltransferases (Zhang and Reinberg 2001; Volkel and Angrand 2007).  
Almost all of these modifications on amino acid residues share a common feature. 
They are active processes, requiring enzymes that catalyze the deposition of 
chemical groups to the amino acid residue. Therefore enzymes exist that remove 
the groups again if needed, e.g. during differentiation when gene transcription 
profiles change due to cell specification. This process is dynamic and e.g. 
responsible for the increasing proportions of heterochromatin towards terminal 
differentiation that reflects the ongoing deposition of repressive marks (Sparmann 
and van Lohuizen 2006; Turner 2007). 
Chromatin Modifications Residues Modified Functions Regulated 
Acetylation K-ac Transcription, Repair, Replication, Condensation 
Methylation (lysines) K-me1 K-me2 K-
me3 Transcription, Repair 
Methylation (arginines) R-me1 R-me2a R-
me2s Transcription 
Phosphorylation S-ph T-ph Transcription, Repair, Condensation 
Ubiquitylation K-ub Transcription, Repair 
Sumoylation K-su Transcription 
ADP ribosylation E-ar Transcription 
Deimination R > Cit Transcription 
Proline Isomerization P-cis > P-trans Transcription 
Table 1: Different histone modifications 
Overview over the different histone modifications found up to date. Residues that 
are modified are given in the 1 letter amino acid code and the functional outcome is 
listed. Adpated from Kouzarides, 2007. 
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3.2.1.1 The polycomb repressive complex 1 and 2 
In Drosophila, polycomb group genes (PcG) genes were identified to repress Hox 
genes during developmental patterning. Mutations of PcG members results in 
incorrect de-repression of Hox genes and disrupts correct spatial and temporal 
patterning during embryonic development. The phenotype was named polycomb, 
since body segementation was posteriorized and showed additional sex combs 
(Ringrose and Paro 2004; Sparmann and van Lohuizen 2006; Alexander, Nolte et 
al. 2009). In vertebrates, Hox gene mis-expression, caused by PcG mutations, lead 
among others to skeletal phenotypes (Akasaka, Kanno et al. 1996; Lorente, Marcos-
Gutierrez et al. 2000). The PcG genes encode two distinct complexes that both are 
able to remodel chromatin, namely polycomb repressive complex 1 (PRC1) and 
polycomb repressive complex 2 (PRC2).  
PRC1 is composed of the core components Ring1A/B, Bim1, Cbx and Phc. 
Ring1A/B are E3 ubiquitin ligases and therefore the catalytic subunit of PRC1 
catalyzing the ubiquitination of histone H2A at lysine 119. H2AK119ub1, a 
repressive mark, inhibits gene transcription (Levine, Weiss et al. 2002; Wang, Wang 
et al. 2004). The Cbx protein of PRC1 has a chromodomain that recognizes the 
H3K27me3 mark set by PRC2. One can assume that these events might be causal 
to each other, but reports already showed that chromatin compaction occurs even 
without ubiquitination activity of Ring1B and partially, ubiquitination of H2A119 takes 
place without recruitment of PRC1 by H3K27me3 (Eskeland, Leeb et al. 2010; 
Tavares, Dimitrova et al. 2012).  
The PRC2 is composed of 4 core subunits Ezh2, Eed, Suz12 and RbAp46/48 
(Margueron and Reinberg 2011). Ezh2 with its SET-domain is the catalytic subunit 
of PRC2 that catalyzes the mono-, di- and trimethylation of H3K27 (H3K27me1, 
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H3K27me2, H3K27me3) (Shen, Liu et al. 2008; Schuettengruber and Cavalli 2009). 
Eed is a linker between histone H3 substrates and Ezh2 (Tie, Stratton et al. 2007) 
and Suz12 is needed to stabilize Ezh2 and for nucleosome recognition (Pasini, 
Bracken et al. 2004; Nekrasov, Wild et al. 2005). In vitro experiments showed that 
RbAp46/48, a histone binding protein, binds to PRC2 and enhances its enzymatic 
activity (Cao and Zhang 2004). Straight knock-outs of Eed, Suz12 or Ezh2 in mice 
showed similar phenotypes, pointing to the coordinated function of the PRC2 
complex members. Mice lacking one of these proteins die around gastrulation. 
Therefore it is not possible to use them to study in vivo functions of PRC2 members 
at later developmental stages (Faust, Schumacher et al. 1995; O'Carroll, Erhardt et 
al. 2001; Pasini, Bracken et al. 2004). PRC2 acts as a transcriptional repressor, 
since the H3K27me3 mark is found mainly at silenced promoters (Mikkelsen, Ku et 
al. 2007; Schuettengruber, Chourrout et al. 2007). In mammals, PRC2 is involved in 
repressing developmental regulators in mouse embryonic stem cells (mESCs) and 
PRC2 regulates the proliferation and differentiation of stem cells (Boyer, Plath et al. 
2006; Margueron and Reinberg 2011). PRC2-Ezh1 is an additional mammalian 
PRC2 complex with Ezh1 substituting for Ezh2. The PRC2-Ezh1 has a similar 
molecular weight as PRC2-Ezh2 but exhibits lower methyltransferase activity. The 
way to repress gene transcription is different for both complexes. Knockdown of 
Ezh1 does not change global H3K27me3 levels but PRC2-Ezh1 is able to 
condensate chromatin. The targets of Ezh1 and Ezh2 are just partially overlapping 
and only a double knock-out of Ezh2 and Ezh1 abolishes H3K27me3 completely in 
ESC, resulting in a de-repression of H3K27 target genes (Margueron, Li et al. 2008; 
Shen, Liu et al. 2008). Additional information for redundant functions of Ezh1 and 
Ezh2 comes from work in skin development. Ezh2, abundant in epithelial stem cells, 
declines during differentiation and Ezh1 expression increases in terminal 
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differentiated layers, indicating that Ezh1 overtakes Ezh2 function in more 
differentiated tissues (Ezhkova, Pasolli et al. 2009; Ezhkova, Lien et al. 2011).  
An unsolved question is how PRCs get recruited to their target genes. In Drosophila 
the search was already narrowed down. DNA consensus sites for binding of PHO 
and PHO-like, both zinc finger proteins, are essential for the recruitment. This 
complex, called PHO-RC interacts physically with subunits of PRC2 and PRC1. 
PHO mutants de-repress Hox genes, because of PRC1 and PRC2 missing at Hox 
gene PREs (Wang, Brown et al. 2004; Mohd-Sarip, Cleard et al. 2005; Klymenko, 
Papp et al. 2006). However, up to now no PRE could be identified in mammals. 
Data points to a more complex regulation, involving many different factors and 
tissue specific recruitment. Oct4 and/or Yy1 are candidates for recruitment factors of 
PRCs, but one has to keep in mind their own tissue specific expression. Further, 
other epigenetic marks like CpG islands are discussed and ncRNAs were suggested 
for PRC recruitment, too (Squazzo, O'Geen et al. 2006; Rinn, Kertesz et al. 2007; 
Ku, Koche et al. 2008; Zhao, Sun et al. 2008). An overview about PRC1 and PRC2 
and their respective member is given in Figure 10. 
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Figure 10: The polycomb repressive complexes 1 and 2 
The polycomb repressive complex 2 consists of four core proteins, RBAP48, 
SUZ12, EED and EZH2 with its SET-domain. Ezh2 activity as methylatransferase 
requires interactions with the other complex members. PHF1 is not part of the core 
complex itself, but required for chromatin binding of the complex. PRC1 has 4 core 
members, as well. PH1, BMO1 CBX, with its chromo-domain and RING1B, an 
ubiquitin ligase for ubiquitinination of H2AK119. CBX and the chromodomain are 
recognizing the H3K27me3 mark set by polycomb repressive complex 2. Adapted 
from Eckert et al., 2010. 
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3.2.1.2 Ezh2  
The gene for enhancer of zeste homolog 2 (Ezh2) lies on chromosome 6 in mice. It 
spans over ~65 kbps. The protein is encoded from 20 exons and the exons 16-20 
encode for the SET-domain of Ezh2. The SET-domain is the catalytic subunit of 
Ezh2 and with that for the whole PRC2. Ezh2 belongs to the EZH family of SET-
domain containing proteins. N-terminally to the SET-domain it has a 15aa cysteine 
rich residue but no post SET-domain and the protein comprises 2 SANT-domains. 
The counter-actors of Ezh2 activity are jmjC-domain containing enzymes that de-
methylate H3K27me3. Uty, Utx and jmjd3 are known H3K27me3 demethylases 
(Volkel and Angrand 2007).  
 
Ezh2 is required in many different cellular processes and a crucial protein in 
development, as all PRC2 members. Embryos lacking Ezh2 die during gastrulation 
(O'Carroll, Erhardt et al. 2001), and ESCs in vitro devoid of Ezh2 expression show 
differentiation defects, whereas maintenance or self-renewal stays largely 
unaffected due to compensation of Ezh1 (Shen, Liu et al. 2008). In limb 
development of mice, Ezh2 has a crucial role in the anterior-posterior axis 
specification and proximodistal axis elongation (Wyngaarden, Delgado-Olguin et al. 
Figure 11: Ezh2 protein with main domains 
Schematics of Ezh2 protein structure with 2 SANT domains for interactions with 
histones, a cystein rich 15 amino acid residues before the SET domain, which is the 
catalytic subunit of the protein and the whole polycomb repressive complex 2. The 
Ezh2 protein itself is 746 amino acids in length.  
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2011). Another report showed the occupancy of H3K27me3 over the HoxD cluster 
during mouse tail development (Soshnikova and Duboule 2009). In cortical 
development it was already shown that Ezh2 is responsible for the switch of neural 
stem cells from the neurogenic to the gliogenic phase. Interestingly, differentiation 
was not affected per se (Hirabayashi, Suzki et al. 2009). Another report showed 
similar results pointing to a role for Ezh2 in the timing of cortical development 
regulating the timing of the neurogenic phases (Pereira, Sansom et al. 2010). In 
skeletal muscle cell differentiation, Ezh2 knockdown results in premature 
differentiation of myoblasts to myotubes, pointing again to a role of Ezh2 as a 
maintenance factor, like in neural stem cells (Caretti, Di Padova et al. 2005; Juan, 
Kumar et al. 2009). Further, the H3K27me3 demethylase Utx was described to be 
involved in the demethylation of muscle specific genes during myogenesis, showing 
the opposing roles of these counteracting enzymes in muscle cell differentiation 
(Seenundun, Rampalli et al. 2010). In epidermal differentiation Ezh2 exerts similar 
functions. Upon knock-out of Ezh2 in epithelial stem cells, differentiation accelerates 
and self-renewal is impaired. Again, Ezh2 acts as a maintenance factor for stem 
cells, keeping them in an undifferentiated state, and further Ezh2 regulates self-
renewal in these cells (Ezhkova, Pasolli et al. 2009; Zhang, Bardot et al. 2012). It 
was directly shown that Ezh2 is a cell cycle regulator, too. Ezh2 regulates the 
Cdkn2a locus and by itself gets regulated by posttranslational protein modifications. 
Phosphorylation of tyrosine residue 641 of Ezh2 by CDKs is needed to regulate 
Ezh2 activity during cell cycle and probably to spread the H3K27me3 mark through 
cell divisions (Chen, Bohrer et al. 2010; Kaneko, Li et al. 2010; Zeng, Chen et al. 
2011). Ongoing, Ezh2 and various other PRC2 members are described to be mis-
regulated in different cancers, like prostate cancer, lymphoma or glioblastoma. Ezh2 
is a proposed oncogene. The functional outcome differs, but again inappropriate cell 
state maintenance and/or cell cycle misregulation are two key features of Ezh2 
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misregulation in cancers. Downstream of the pRB-E2F transcription factor pathway, 
Ezh2 is associated with cell proliferation, whereas Ezh2 overexpression would lead 
to hypermethylation of tumor suppression genes (Bracken, Pasini et al. 2003; 
Pasini, Bracken et al. 2004; Suva, Riggi et al. 2009; Qi, Chan et al. 2012).  
 
 
Figure 12: Polycomb repressive complex 2/Ezh2 and subsequent effects 
Enhancer of zeste homolog 2 as a subunit of polycomb repressive complex 2 catalyzes 
the trimethylation of H3K27. This modification can be „read“ by polycomb repressive 
complex 1, what leads to ubiquitination of H2AK119. Chromatin compaction and 
repression of gene transcription is the result. Further data indicates the direct 
interaction of enhancer of zeste homolog 2 with DNA methyltransferases that methylate 
DNA, another mechanism to repress gene transcription. Adapted from Sparmann and 
van Lohuizen, 2006. 
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3.2.2 RNA interference 
With the finding of micro RNAs (miRNA) and non-coding RNAs (ncRNA) in 
nematodes and mammalians, respectively, it became obvious that gene expression 
can be regulated by RNAs, too (Borsani, Tonlorenzi et al. 1991; Brockdorff, 
Ashworth et al. 1992; Wightman, Ha et al. 1993). First considered as rare 
exceptions to already known ncRNAs, like ribosomal RNA or transfer RNA, it 
became obvious, over the following years, that thousands of ncRNAs are encoded 
in the genome and that they are involved in almost every biological aspect (Carninci 
2009; Jacquier 2009; Mercer, Dinger et al. 2009). A popular example, linked to the 
PRC2, for ncRNA regulation of gene expression in mammalians is Xist. Functionally, 
Xist helps balancing gene dose of X-chromosomal genes between sexes. This X-
chromosomal inactivation is mediated by a genomic region called ‘X-inactivation 
center’ (Xic), encoding for at least 7 ncRNAs (Lee 2009). A 17kbp long transcript 
from that locus is Xist. It acts in a negative feedback loop, inactivating first the locus 
and subsequently the chromosome it is transcribed from. Xist by itself recruits PRC2 
resulting in H3K27me3 methylation of the 5’ end of Xist. Starting from there the 
whole X-chromosome gets repressed in a Xist dependent manner (Zhao, Sun et al. 
2008). Another example for ncRNA regulation of gene expression are Hox genes. 
Transcription of non-coding regions of the Hox cluster can regulate the expression 
of neighboring Hox genes. A HOX antisense intergenic RNA (HOTAIR) was found in 
humans. HOTAIR has a silencing activity, due to its interactions with PRC2 and a 
complex containing the H3K4me3 demethylase LSD1. The repression of the HOXD 
cluster and other loci is HOTAIR-dependent (Rinn, Kertesz et al. 2007; Tsai, Manor 
et al. 2010; Pauli, Rinn et al. 2011). 
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3.2.3 DNA methylation 
Another epigenetic mark that was described to be repressive is the methylation of 
cytosine residues occurring in CpG dinucleotides. CpG islands, meaning stretches 
of DNA containing more than statistically expected CG- nucleotide palindromes, 
were found on more than 50% of the genes in vertebrate genomes and especially 
around promoters. DNA methylation is an active process requiring DNA 
methyltransferases (DNMTs). DNMT1, DNMT3A and DNMT3B are described DNA 
methyltransferases. Since epigenetic modifications are heritable it was thought that 
DNMT1 would overtake functions in re-methylating one DNA strand after cell 
division and is therefore called maintenance DNMT. Further studies on the function 
suggested interactions with other protein complexes refusing DNMT1 to act alone 
on DNA methylation maintenance. On the other hand, DNMT3A and DNMT3B are 
de novo methyltransferases (Bird 2002; Cedar and Bergman 2012). An in vivo 
knock-out of any of these enzymes results in embryonic lethality, emphasizing the 
crucial role of DNA methylation for development of vertebrates (Li, Bestor et al. 
1992; Okano, Bell et al. 1999). Contrary, all three DNMTs are dispensable for the 
self-renewal ability of ESCs in vitro (Tsumura, Hayakawa et al. 2006). This data 
points to roles of DNMTs in specific cellular functions that have to be elucidated 
further. Again showing the complementary functions of epigenetic modifications, 
interaction of Ezh2 and DNMTs was already shown, suggesting that Ezh2 action, 
and with it H3K27 trimethylation, directly controls DNA methylation via recruiting 
DNMTs (Vire, Brenner et al. 2006). This interlink of Ezh2 and DNMTs was shown in 
cancer, too (Schlesinger, Straussman et al. 2007). 
 Introduction 
 
- 34 - 
 
3.3  The Cre-loxP system 
Transgenic mice became a valuable tool for biological research. Especially the 
Cre/loxP system allowed studies in tissue specific stem cells and their progeny. 
Another advantage is circumvention of early lethality of straight knock-outs of some 
genes in animals. The Cre/loxP system requires the introduction of loxP sites next to 
exons/genes that should be cut out on mice.  On the other hand, one needs the Cre-
recombinase, an enzyme that recognizes the loxP sites with different outcomes 
dependent on the orientation of the loxP sites. Are the loxP sites directly repeated 
the recombination event will result in an excision of the targeted DNA sequence 
within the loxP sites. If they would be inverted, this would result in an inversion of 
the targeted DNA sequence. In dependency of the promoter used to drive the Cre-
recombinase expression, one can control tissue specificity and timing of Cre-
recombinase activity and with that the deletion of the gene of interest. Manifold 
usages are applied today. Firstly, used to delete genes in a spatio-temporal 
controlled manner, one can also use the Cre/loxP system to delete STOP-codon 
that are inserted before genes, e.g. for overexpression of genes or to express a 
reporter gene, like LacZ for lineage tracing of recombined cells (Sauer and 
Henderson 1988; Turan, Galla et al. 2011).  
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4 Material and Methods 
4.1 Animals and genotyping 
The Cre-loxP system (Sauer and Henderson 1988; Turan, Galla et al. 2011) was 
used to conditionally ablate Ezh2 in NCCs. Mice carrying a transgene, where 2 
exons encoding for the SET-domain of Ezh2 are flanked by loxP sites, are described 
(Hirabayashi, Suzki et al. 2009) and shown in Figure 13. Homozygous animals 
(Ezh2lox/lox) were crossed with animals carrying the Wnt1-Cre transgene (Danielian, 
Muccino et al. 1998) and that are heterozygous for the floxed Ezh2 allele (Wnt1-Cre; 
Ezh2lox/wt). Offspring with the genotype Wnt1-Cre; Ezh2lox/lox are termed Ezh2 cko 
and got compared to their respective littermates with genotypes having either no 
Wnt1-Cre transgene (Ezh2lox/lox or Ezh2lox/wt) or lacking a second copy of the floxed 
Ezh2 transgene (Wnt1-Cre, Ezh2lox/wt) since these animals never showed an overt 
phenotype and the lastly mentioned served as mating studs with normal life-time 
expectations. Ezh2 cko mice survived to late developmental stages although they 
never got born. Time mating’s were done o/n and noon on the following day was 
considered as embryonic day (E) 0.5. In vivo fate mapping of NCCs was done on 
mice additionally carrying the R26R-LacZ allele (Soriano 1999) that gets activated 
upon Cre mediated recombination to express β-galactosidase.  
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Genotyping was done by PCR on genomic DNA obtained from tails. The primers 
used are listed in Table 2. 
 
 
 Forward primer Reverse primer 
Wnt1-Cre ATGCCCAAGAAGAAGAGGAAGGT GAAATCAGTCGCTTCGAACGCTAGA 
Ezh2 wt AAGGCTGTGTACAGGAAACAA AGTACTCCATACAGGAAACAATC 
Ezh2 fl AAGGCTGTGTACAGGAAACAA TCACCTTAATATGCGAAGTGGAC 
LacZ GGTCGGCTTACGGCGGTGATTT AGCGGCGTCAGCAGTTGTTTTT 
Table 2: Primers for PCR 
Figure 13: Ezh2 alleles 
The exons 16-20 of the wild-type allele of 
Ezh2 are shown. These exons encode the 
SET-domain of Ezh2. 
The exons 18 and 19 are flanked by loxP 
sites in the flox allele. 
Upon Cre-mediated recombination exons 
18 and 19 are deleted and with that the 
encoded protein lacks a funcional SET-
domain. 
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4.2 Immunohistochemistry, X-Gal staining and EdU staining 
For immunohistochemistry, 14-µm thin cryosections were fixed 10 minutes in 4% 
formaldehyde in PBS at room temperature, on purpose followed by an antigen 
retrieval with 10mM citrate buffer, pH 6, for 10 minutes at 110°C in a microwave, 
then blocked 1 hour in blocking buffer (1% BSA, 0.3% Triton-X100 in PBS) at room 
temperature and incubated with the respective primary antibody ( see Table x) at 
4°C o/n. Secondary antibody incubation was done 1 hour at room temperature. 
DAPI (1:2000) staining was done 5 minutes at room temperature; afterwards the 
slides were mounted and covered for analysis. Primary antibodies were used as 
follows: rabbit anti-PHH3 (1:200, Millipore), mouse anti-tyrosine hydroxylase (TH) 
(1:200, Sigma), mouse anti-Mash1 (1:100, BD Biosciences), rabbit anti-Brn3a 
(1:2000, a gift from E. E. Turner, Seattle Children’s Research Institute, Seattle, WA, 
USA), mouse anti-Neurofilament 160 (1:400, Sigma), rabbit anti-Neurofilament M 
(1:200, Chemicon), rabbit anti-Ki67 (1:200, Abcam), rabbit anti-FABP (1:4000, a gift 
from C. Birchmeier, Max Delbrück Center for Molecular Medicine, Berlin, Germany), 
rabbit anti-cleaved Caspase-3 (1:200, Cell signaling), rabbit anti-H3K27me3 (1:200, 
Millipore), rabbit anti-Oct6 (1:200,), rabbit anti-Collagen2a1 (1:200, Acris). 
Fluorescence conjugated antibodies were from Jackson ImmnunoResearch or 
Invitrogen. LacZ reporter gene expression was detected by incubating the embryos 
stage dependent (2 to 12 hours) at 37°C in PBS containing 1 mg/ml X-Gal 
(Applichem), 10 mM K3Fe(CN)6, 10 mM K4Fe(CN)6, 2 mM MgCl2 and 0.02% NP40. 
Reaction was stopped by placing the embryos in PBS. EdU stainings were done 
according to the manufacturer’s protocols (Invitrogen). EdU was injected 1 hour 
before euthanization intra-peritoneal of time mated animals at E11.5. 
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4.3 Primary cell culture isolation (BA1 cells) 
BA1 cells were mechanically isolated from E11.5 embryos and kept separately on 
ice. The BAs were digested in HBSS (Gibco) containing 0.025% Trypsin (Gibco) and 
0.35 mg/ml collagenase type I (Worthington) for 15 minutes at 37°C. The reaction 
was stopped by adding 10% FCS (Gibco) to the digestion mixture. Cells were 
spinned down for 5 minutes with 1200 rpm and re-suspended in buffers applicable 
for further experiments and stored until genotyping was done (see also Figure 14).  
 
 
4.4 Cell cycle FACS analysis 
Wnt1-Cre; Ezh2lox/lox and Ezh2lox/lox BA1 cells, isolated as described in 4.3, were 
taken up in 500 µl PBS incubated 15 minutes on ice containing 1.25 mM 5-AAD 
(Sigma), washed twice in PBS and then analyzed using a FACS Canto II flow 
cytometer (BD Bioscience). FlowJo software (Tree Star) was used to analyze the 
data.  
Figure 14: Worklow of BA1 cell isolation from E11.5 embryos 
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4.5 Quantitative RT-PCR and ChIP-q-PCR 
For mRNA isolation we used the RNeasy Minikit (Quiagen). 0.5 µg of total mRNA 
from BA1 cells served as template for reverse transcription with Oligo-dT primers 
(Invitrogen) and superscript III polymerase (Invitrogen). The q-PCR reaction was 
performed on a LightCycler II (Roche). Each experiment was done in triplicates and 
three independent q-PCR reactions were afterwards analyzed with the delta Ct-
method. β-actin was used for normalization. Primers are listed in Table 3  
 Forward primer Reverse primer 
Ezh2 E5-8 GGGCTATCCAGACTGGTGAA AAATTGCCCACAGTACTCAAGG 
Ezh2 E18-19 GTGACCACAGGATAGGCATCT CAAGGGATTTCCATTTCTCG 
Hoxa2 TACGAATTTGAGCGAGAGATTGG GTCGAGGTCTTGATTGATGAACT 
Hoxa3 CCCACAGAAACGCTACACAG GAGTGGCCCAGAGTTGCTC 
Hoxb4 TCCGAGCGCCAGATCAA CCGAGCGGATCTTGGTGTT 
β-actin CCATCCTGCGTCTGGACCTG GTAACAGTCCGCCTAGAAGC 
Runx2 ATGCTTCATTCGCCTCACAAA GCACTCACTGACTCGGTTGG 
Osterix TGGCCATGCTGACTGCAGCC TGGGTAGGCGTCCCCCATGG 
ALP TGACCTTCTCTCCTCCATCC CTTCCTGGGAGTCTCATCCT 
Sox10 CCCACACTACACCGACCAG GTCGTATATACTGGCTGCTCCC 
Sox9 TGAACGCCTTCATGGTGTGG GTTCTTCACCGACTTCCTCC 
Table 3: Primers for q-RT-PCR 
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4.6 Chromatin immunoprecipitation 
For ChIP we followed the protocol described in (Weber, Hellmann et al. 2007). 
Primers targeting the transcriptional start sites (±1000bp) of the respective genes 
are listed in Table 4. 
 
4.7 Alcian Blue and Alizarin Red staining 
Alcian Blue (Fluka AG) and Alizarin red (Chroma Gesellschaft) stainings were done 
following the protocols described in (Nagy 2003). 
4.8 Microarray 
After BA1 cell isolation from E11.5 embryos following the protocol described in 
chapter 4.3 and mRNA extraction we submitted the samples to Functional 
Genomics Center Zurich (FGCZ). We used the Affymetrix A430 platform to compare 
transcriptional differences between Wnt1-Cre; Ezh2lox/lox and Ezh2lox/lox BA1 cells.  
 Forward primer Reverse primer 
Hprt CCAAGACGACCGCATGAGAG CAACGGAGTGATTGCGCATT 
HoxD12 TGGCTCTCAGGTTGGAAAAG GTCCTCCTATTCCGGGTTGT 
Hoxa2 TCTGCTCAAAAGGAGGAGGA  
 
GGAGAAGGCCATGAATTACG 
Hoxa3 CCCAGAGGGACTTCAGTCAG TTACAGCCAGCCTAGGAGGA 
 
Hoxb4 TTCGGAAACAGGAAAACGAG TGGTCGCTGGGTAGGTAATC 
Table 4: Primers for ChIP 
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4.9 Statistical analyses 
Each experiment was done on at least three independent embryos. Calculations 
were done in excel, error bars in figures showing either standard error of mean 
(±SEM) or standard deviation (±SD) as stated in the respective figure legend. 
Statistical significance was tested with an unpaired, two-tailed Student’s t-test. 
 
 Results 
 
- 42 - 
 
5 Results 
 
5.1 Inactivation of Ezh2 in NCCs   
First, we had to check whether the conditional knock out model we are using is 
working in our crossings.  
We analyzed targeting the wt-allele, the introduced transgenic construct including 
the loxP sites or the deletion allele upon Cre-mediated recombination by PCR. This 
was done on tissue probes of control and Ezh2 cko embryos and mice. The PCR 
showed the expected bands with 844 bps for the wild-type allele, 591 bps for the 
floxed allele and 360 bps for the deletion allele (Figure 15).  
 
 
 
 
 
 
 
Figure 15: Ezh2-PCR for the different alleles.  
Ezh2lox/wt;Cre- refers to a Ezh2 wt band of 844 bps and a 591 bps band showing the 
Ezh2 allele having the loxP sites. The Ezh2lox/lox;Cre+ band shows the reduction of 
genomic DNA when Cre gets expressed in the tissue. And Ezh2 cko refers to a 360 
bps long DNA fragment just obtained when Cre and loxP sites are present in the 
tissue. 
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To determine the loss of Ezh2 transcripts, we performed quantitative RT-PCR of 
mRNA isolated from BA1 cells of E11.5 control and Ezh2 cko embryos (Figure 16). 
We used 2 different primer sets, namely primers targeting Ezh2 Exon 18 and 19 and 
Ezh2 Exon 5 to 8 (Ezh2 E18-19 and Ezh2 E5-8). The Ezh2 E18-19 primers bind to 
regions in the mRNA transcript that encodes part of the SET-domain and the Ezh2 
E5-8 primer set is targeting a sequence that starts on Exon 5 spanning until Exon 8, 
therefore lying more 5’ to the Ezh2 E18-19 primers. Both quantitative RT-PCRs are 
showing a comparable and significant reduction of the Ezh2 mRNA transcript in 
Ezh2 cko embryos when compared to controls. Therefore one can assume that the 
mRNA transcripts in Ezh2 cko mice are not transcribed or immediately degraded.  
 
 
 
 
 
 
 
 
 
 
Figure 16: Significant losses of Ezh2 transcripts 
A q-RT-PCR with 2 different primer sets revealed a reduction of Ezh2 transcripts 
in BA1 cells of E11.5 Ezh2 cko embryos when compared to controls. The Ezh2 
E18-19 primer targets the SET-domain in the Ezh2 mRNA, the Ezh2 E5-8 primer 
set binds more 5‘ than the Ezh2 E18-19 primer set. *P<0.05. 
 Results 
 
- 44 - 
 
After already seeing that the mRNA levels of Ezh2 are significantly reduced we 
looked for the major functional read-out of Ezh2 activity and performed 
immunohistochemistry for H3K27me3 and we observed a loss of the mark in 
virtually all NCCs that populate the BA1 at E10.5 (Figure 17). 
 
  
 
 
 
 
After being sure that H3K27me3 is gone at early stages of NC development as 
shown in Figure 17, we examined the persistence of the loss of the H3K27me3 mark 
at late stages of embryonic development. For that we checked trunk NC derivatives 
of E17.5 control and Ezh2 cko embryos for H3K27me3 with immunohistochemistry. 
Both, DRG and AG of Ezh2 cko embryos are still devoid of H3K27 trimethylation at 
E17.5 upon Wnt1-Cre mediated knock-out in NCCs. To mark the structures we 
double labeled the AG with tyrosine hydroxylase (TH), a terminal differentiation 
marker for dopaminergic neurons and sensory neurons in the DRG we marked with 
neurofilament 160 (NF160). Both terminal differentiation markers were present in 
AG and DRG of control and Ezh2 cko embryos, even though the H3K27me3 mark is 
gone (Figure 14). 
Figure 17: Loss of H3K27me3 in BA1s  
Transversal sections of BA1s of control and Ezh2 cko embryos reveals the specific 
loss of H3K27me3 in the NC derived mesenchyme. The cells of the epidermal layer 
still have H3K27me3. Scale bars: 50µm. 
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Taken together these results demonstrate loss of Ezh2 activity in NCCs upon a 
conditional knock out of Ezh2 in NCCs from early time-points of NC development 
(E10.5) to late stages like E17.5. 
Figure 18: Loss of H3K27 trimethylation in E17.5 Ezh2 cko embryos 
Checking for H3K27me3 in trunk neural crest derivatives, like AG and DRG revealed 
the absence of H3K27 trimethylation in Ezh2 cko mice at E17.5. However, terminal 
differentiation markers, like TH for dopaminergic neurons and NF160 are still 
present. Scale bars: 50µm.  
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5.2 Migration properties of NCCs are not impaired by loss of Ezh2 
So we went on and checked for the early event of NC development and the possible 
effects of conditional Ezh2 ablation in NCCs. In addition to Ezh2 ablation, we used 
the ROSA26 Cre reporter allele (R26R) (Soriano 1999), where upon Wnt1-Cre 
mediated recombination all NCCs express β-galactosidase, allowing us to track 
NCCs that some when in their lifespan expressed Wnt1.  
At E10.5 we did not observe differences between Ezh2 cko embryos and controls 
that were stained with X-Gal for β-galactosidase activity. NCCs migrate to and 
populate the structures that are supposed to get built up by NCCs, like BAs or DRG 
(Figure 19).   
 
 
 
Figure 19: Migration of NCCs is not impaired 
The patterns of X-Gal positive cells are the same in E10.5 control and Ezh2 cko 
embryos, pointing to a normal migration, population and survival in the BAs and 
trunk derivatives of Ezh2 cko NCCs. Scale bars 2mm. 
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At E11.5 it is still not possible to distinguish Ezh2 cko embryos from control embryos 
macroscopically and still the NCCs traced with X-Gal staining show comparable 
expression patterns (Figure 20).  
 
 
 
 
 
 
 
 
These results suggest that early events of NC specification, migration and the 
survival in the respective target structures are not heavily affected by the loss of 
Ezh2 in NCCs since up to E11.5 control and Ezh2 cko embryos are not 
distinguishable from each other when staining with X-Gal for NCCs.  
Figure 20: E11.5 Ezh2 cko embryos are still not distinguishable  
X-Gal positive cells are still comparable between control and Ezh2 cko embryos at 
E11.5. Structures are populated and the neural crest cells survive in their 
environment. Scale bars 2mm. 
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5.3 Ezh2 depletion in NCCs causes severe craniofacial defects  
After realizing that the early events of NC development, like specification, migration 
and population of target structures is not impaired upon conditional deletion of Ezh2 
in NCCs we decided to look at later stages of development. At E12.5 we were able 
to distinguish between Ezh2 cko and control embryos since the phenotype becomes 
apparent (Figure 21). At this stage the remodeling process of the intermediate BAs 
and FNP NCCs starts and hey build up their final structures. The Ezh2 cko embryos 
lack the snout but are still alive. 
 
 
 
 
 
 
 
The phenotype is shown on E14.5 Ezh2 cko embryos carrying the R26R allele and 
stained for X-Gal (Figure 22). Ezh2 cko embryos are missing the complete 
craniofacial region, although some residual cells are still positive for β-galactosidase 
Figure 21: The phenotype becomes apparent at E12.5  
In Ezh2 cko embryos the phenotype becomes appearent at E12.5. Most remarkebly, 
they lack the snout pointing to a loss of craniofacial derivatives, derived from cranial 
neural crest cells. Contrary to the facial region, the body looks normal. Scale bars: 
2mm. 
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activity (Figure 12). The Ezh2 cko embryos change their cranial morphology due to 
the absence of the stabilizing tissue of the craniofacial region and therefore the head 
bends over. In addition we observed that Ezh2 cko embryos with the R26R allele 
have peripheral nerves (arrowheads) at the level of the hindlimbs and these are 
comparable to their control littermates what points to a normal development of 
peripheral nerves in Ezh2 cko embryos (Figure 22).  
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Phenotype on X-Gal stained E14.5 embryos  
A and B: E14.5 embryos stained with X-Gal show the craniofacial phenotype already 
observed at E12.5. But even in the head region residual X-Gal positive cells are 
seen. 
C and D: higher magnification of the hindlimb region of the embryos shown in A and 
B. The arrowheads point to peripheral nerve that seem unaffected. 
Scale bars: A and B: 2mm; C and D: 1mm; HL: hindlimbs  
 Results 
 
- 50 - 
 
The embryos survive to late developmental stages but never got born. The latest 
studies we performed on embryos were at E17.5. At this stage the embryos show 
comparable size in total but the missing structures from the craniofacial areas cause 
a severe phenotype in the head region (Figure 23).  
 
Figure 23: Severe craniofacial phenotype upon Ezh2 cko at E17.5 
The phenotype shown on E17.5 embryos. Looking quite normal in trunk regions, the 
massive phenotype, the lack of craniofacial structures, prevents viability since we 
never saw newborns. Scale bars: 2mm. 
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5.4 Ezh2 is not required for differentiation of trunk NCCs 
To check for the role of Ezh2 in trunk NCC differentiation we performed 
immunohistochemistry stainings on E17.5 embryos of Ezh2 cko and control 
embryos transversal sections. At these later stages of development any phenotype 
might have manifested and would be easily detectable.  
First checking for sensory neurogenesis we stained for Brn3a, a marker for 
progenitor cells of the sensory lineage in DRG (Eng, Lanier et al. 2004). Additionally 
we stained the DRG for NF160 to check for terminal differentiation of neurons. Both 
markers showed no obvious differences when comparing control to Ezh2 cko DRG 
(A and B in Figure24). 
Then we did stainings for the progenitor and terminal differentiation markers of 
neuronal, autonomous differentiation.  Mash1, a progenitor marker for autonomous 
neurons is not changed. To visualize the AG we stained for NeurofilamentM in 
addition to Mash1 (C and D in Figure24). Further checking for tyrosine hydroxylase 
(TH), a marker for terminal differentiated autonomic neurons and again 
neurofilamentM showing the presence of both in AG when comparing E17.5 Ezh2 
cko embryos with control embryos (E and F in Figure24).  
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Figure24: Immunohistochemistry for neuronal markers of trunk NCCs 
A and B showing DRG of control and Ezh2 cko embryos stained for Brn3a a 
sensory, neuronal progenitor marker and NF160 to mark terminal differentiated 
neurons, showing no differences. 
C – F showing AG of control and Ezh2 cko E17.5 embryos with no obvious 
differences in progenitor marker expression (Mash1 in C,D) and terminal 
dopaminergic marker expression (TH in E,F). Double staining with NFm marks the 
location of the AG.  
Scale bars: 50µm 
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After excluding possible neuronal differentiation defects we thought about the glial 
lineage of trunk NCCs. So we looked for Schwann cells, the myelin producing cells 
of the peripheral nervous system, checking for a marker expressed in premature 
Schwann cells and we were able to find cells expressing Oct-6 in Ezh2 cko mice 
comparable to controls peripheral nerves. To mark the peripheral nerves we stained 
for NF160 additionally to Oct-6 (E and F in Figure 25).  
Next we wanted to see whether glial differentiation markers in DRG are changed 
and we were not able to examine differences comparing Ezh2 cko embryos against 
control embryos. We performed immunohistochemistry for glial fibrillary acidic 
protein (GFAP) a late marker of glial differentiation. At E17.5 we couldn’t see 
changes in the expression of GFAP in DRG when comparing Ezh2 cko embryos 
against control littermates (A and B in Figure 25). Further we performed 
immunohistochemistry for an early marker of glial differentiation, like fatty acid 
binding protein (FABP). This marker didn’t show alterations upon Ezh2 ablation, too 
(C and D in Figure 25). These results lead us to the conclusion that we are not 
interfering in the differentiation steps of trunk NCCs in DRGs and AGs neither 
neuronal nor glial in these later developmental stages.  
 
 Results 
 
- 54 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Immunohistochemistry for glial markers of trunk NCCs 
A and B showing presence of GFAP a late glial marker in DRG of control and Ezh2 
cko animals.  
C and D showing no differences in FABP abundance, an early glial marker.   
E and F showing peripheral nerves, marked with NF160 of Ezh2 cko and control 
animals and both have the cmparable Oct6 expression a marker for premature 
Schwann cells.  
Scale bars: 50µm. 
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5.5 Ezh2 cko embryos lack chondrogenic and skeletal elements  
The conditional ablation of Ezh2 in NCCs results in the loss of all chondrogenic 
structures that build up the skeletogenic elements of the craniofacial structures as 
shown by alcian blue staining. At E14.5 Ezh2 cko embryos are lacking the upper 
and lower jaw and the nasofrontal plate (Figure 26). All these derivatives are built up 
by CNCCs since this subpopulation of NCCs has mesenchymal potential (see 
chapter 3.1.4.1). Partially, these chondrogenic elements are just a template for 
bones therefore we checked for later stages, too.  
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Figure 26: E14.5 Ezh2 cko embryos show a loss of chondrogenic elements in 
the facial region 
A and B: The loss of chondrogenic elements in the facial region of E14.5 Ezh2 cko 
is shown by Alcian Blue staining.  
C and D show higher magnification of the head region of the embryos in A and B. 
Scale bars 2mm. 
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At E17.5 almost all facial skeletal elements are absent in Ezh2 cko embryos as 
shown in Figure 23 and Figure 27. Elements completely derived from CNCCs are 
missing, whereas skull bones in which CNCCs are just contributing to, look 
abnormal but are established (Jiang, Iseki et al. 2002; Gross and Hanken 2008). We 
still see parts of the parietal skeletal plate (p in Figure 27) and the interparietal plate 
exists (ip in Figure 27). Bones derived exclusively from CNCCs, like the mandible, 
maxilliary (md and mx in Figure 27) or the frontal-plate (f in Figure 27) is completely 
missing in Ezh2 cko embryos at E17.5. Chondrogenic elements are partially 
established as seen from the otic capsule (o in Figure 27) but more rostrally/anterior 
the chondrogenic elements look abnormal.  
 
 
 
 
 
 
To elucidate the observed phenotype further that becomes apparent at E12.5 and 
causes a massive loss of craniofacial NC derivatives at later stages, we decided to 
check for the precursor cells that build up these structures.  
Figure 27: Almost all neural crest derived craniofacial elements are missing in
E17.5 Ezh2 cko embryos 
A combined Alizarin Red and Alcian blue staining on E17.5 control and Ezh2 cko 
embryos shows a loss of chondrogenic and skeletogenic elements in the facial region 
of Ezh2 cko embryos when compared to control littermates. 
Mx: maxilliary; md: mandible; n: nasal plate; f: frontal plate; p: parietal plate; ip: 
interparietal plate; o: otic capsule. Scale bars 2mm. 
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Figure 28: Sox10 and Sox9 transcript levels are not changed  
Slight but not significant changes in Sox10 and Sox9 transcripts when comparing 
controls to Ezh2 cko BA1 cells with q-RT-PCR. ±SEM. 
5.6 The transition of NCSCs to MPCs 
After the observation that chondrogenic and skeletogenic elements are missing from 
E12.5 onwards in Ezh2 cko embryos, we asked about the possible cause of this 
phenotype. So we decided to check for cells that differentiate into these derivatives. 
To differentiate into the mesenchymal derivatives of the NC, NCSCs migrating from 
hindbrain levels, caudal to rhombomere 8, undergo a Tgf-β mediated transition to 
become MPCs. These MPCs populate the BAs and subsequently differentiate into 
chondro- and skeletogenic elements of the facial area (see chapter 3.1.4.1). This 
transition step is accompanied by the downregulation of the NCSC transcription 
factor Sox10 and upregulation of the MPC marker Sox9. In order to understand 
whether this transition is affected by Ezh2 conditional ablation we performed a q-RT-
PCR on isolated BA1 cells for Sox10 and Sox9 (Figure 28). No statistically 
significant differences were seen between BA1 cells of Ezh2 cko embryos compared 
to control littermates. 
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5.7 Cell cycle properties of mesenchymal progenitor cells  
One defining criteria for stem/progenitor cells is their self-renewal capacity (chapter 
3.1.2). So we decided to check for the cell cycle properties of MPCs in Ezh2 cko 
mice. A prominent marker for cells in the cell cycle is Ki67. The protein is expressed 
in all phases of the cell cycle, just not in cells that are in G0. When staining for Ki67 
we were not able to observe any major differences in Ki67 abundance in BA1 cells 
of Ezh2 cko and control BA1’s (Figure 29).  
 
 
 
 
 
 
 
Since Ki67 is just giving an indication of cells that are currently in the cell cycle we 
performed further experiments to check for specific phases of the cell cycle. Next we 
examined cells undergoing S-Phase via a pulse of EdU 1 hour prior to euthanization 
of the animals at E11.5 (Figure 30). The quantification showed no significant 
differences in the number of cells that are positive for EdU in the BA1 when 
comparing controls to Ezh2 cko mice. For control animals we counted 46,6 % of 
EdU positive cells and for Ezh2 cko 47,8 % EdU positive cells, respectively. 
Figure 29: Ki67 expression is not changed 
The cell cycle marker Ki67 is not changed in Ezh2 cko BA1’s when compared to 
control BA1’s with immunohistochemistry at E11.5. Scale bars 50µm. 
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Therefore we concluded that cells entering and exiting the S-Phase during a 1 hour 
period of EdU incorporation are not affected.  
 
 
 
 
 
 
 
 
 
Next we checked for cells that are in M-Phase performing a PHH3 staining on BA1 
sections of control and Ezh2 cko mice at E11.5 (Figure 31). Again no significant 
differences could be found between control and Ezh2 cko animals. BA1 sections of 
control animals contained 3,9 % phospho-histone positive and the BA1 of Ezh2 cko 
animals yielded 5,1 % of PHH3 positive cells. 
Figure 30: Comparison of S-phase cells  
The immunohistochemical stainings for the thymidin analogon EdU are depicting the 
cells in BA1 that are in or went through S-phase within a 1 hour time frame of control 
and Ezh2 cko embryos 1 hour after injection and sacrification of the animals. The 
quantification didn’t reveal a significant change in the number of EdU positive, due 
to a loss of Ezh2 in NCCs. ±SEM 
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Lastly, to definitely exclude any cell cycle difference we performed cell cycle 
fluorescence activated cell sorting (FACS) on isolated E11.5 BA1 cells of control 
and Ezh2 cko embryos. The cell cycle profiles of control and Ezh2 cko BA1 cells are 
shown in Figure 32, showing comparable amounts of cells are in the respective 
phases of the cell cycle when comparing BA1 cells of E11.5 control and Ezh2 cko 
embryos.  
 
Figure 31: Comparison of PHH3 positive cells in BA1’s  
The quantification shows the percentual proportions of PHH3 positive cells in BA1 
(DAPI positive cells) of control and Ezh2 cko embryos. ±SEM 
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The quantification of the cell cycle FACS profiles (Figure 32) was done with the 
Dean-Jett-Fox algorithm provided by FlowJo, published in (Fox 1980). The algorithm 
calculated comparable and not significant proportions of cell cycle phases for control 
and Ezh2 cko embryos BA1 cells at E11.5. We find around 31% of the cells in G2-
phase and 38% are detected to be in G1-phase of the cell cycle for both genotypes. 
Additionally, the algorhithm provides a mathematical model to estimate the cells that 
are currently in S-phase. The proportion of cells that are currently in S-phase, is 
approximately 30% in both cases.  
 
 
Figure 32: Cell cycle FACS profiles of E11.5 BA1 cells 
The cell cycle FACS profiles of BA1 cells from E11.5 control and Ezh2 cko 
littermates didn’t reveal changes in different phases of the cell cycle, like G1 and 
G2.  
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After analyzing the cell cycle properties of BA1 cells, we checked for apoptosis. 
Apoptosis could be another event that BA1 cells suffer from and with an impaired 
survival of MPCs Ezh2 cko embryos woud lack craniofacial elements.But after 
staining for Caspase-3 a marker for cells inevitably gone into apotosis we did not 
see differences in the rates of Caspase-3 positive cells between Ezh2 cko embryos 
and controls at E11.5 (Figure 34).  
 
 
 
 
 
Figure 33: Proportions of BA1 cells in 
different cell cycle phases 
The quantification of the cell cycle FACS 
doesn’t show changes in the proportions of 
BA1 cells in each phasewhen comparing 
control to Ezh2 cko BA1 cells. The Dean-
Jett-Fox algorhythm provides a method to 
estimate cells that are currently in S-phase 
in a cell cycle FACS. ±SEM 
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Overall these results demonstrate that Ezh2 conditional knock out in NCCs doesn’t 
change, in the first step the transition of NCSCs to MPCs and subsequently the cell 
cycle properties of MPCs that populate the BAs suggesting that our phenotype is not 
due to cell cycle mis-regulation or apoptosis. That apoptotic rates don’t increase 
might be due to the fact that we are interfering with domains of cells in BAs. So we 
decided to check for the next step, the differentiation of BA1 cells into mesenchymal 
derivatives. BA1 cells undergo chondrogenic and skeletogenic differentiation to build 
up the bones of the craniofacial region.  
Figure 34: No increased apoptosis rates in Ezh2 cko embryos at E11.5 
A staining for Caspase3, to mark cells that irreversibel entered apoptosis, didn’t 
show differences when comparing BA1’s of E11.5 control and Ezh2 cko littermates. 
Scale bars: 50µm. 
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5.8 First indications of chondro-/osteogenic differentiation impairment 
After checking many properties of the MPCs transition stage and seeing that the 
MPC by itself is not severely affected and can be established from NCSCs (Figure 
28) and has normal cell cycle properties (Figure 29, Figure 30, Figure 31, Figure 32, 
Figure 33) we asked about the next progenitor step in the mesenchymal 
differentiation process. So we checked for early markers of osteogenic and 
chondrogenic differentiation in BA1 cells. The first indication for an impairment of 
chondrogenic/skeletogenic differentiation is the absence of Collagen2a1 (Col2a1) 
expression in the BA1 at E11.5 in Ezh2 cko embryos that was not observed in 
control littermates (Figure 35).  
Figure 35: Impairment of chondrogenic differentiation at E11.5  
Col2a1 a marker for chondrogenesis is absent in E11.5 Ezh2 cko BA1’s pointing to 
a chondrogenic differentiation impairment. Scale bars 50µm. 
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After finding an indication for chondrogenic differentiation impairment, we further 
found that Runx2, Osterix and alkaline phosphatase (ALP) are significantly down 
regulated in Ezh2 cko BA1 cells when compared to control BA1 cells as shown by 
quantitative RT-PCR (Figure 36). Runx2, Osterix and ALP  are known markers for 
osteogenic differentiation (Nishimura, Hata et al. 2012). Whereas Runx2 is 
considered to be the main transcription factor for osteogenic differentiation and 
directly regulates Osterix is ALP a later marker for osteogenic differentiation. 
 
 
 
 
 
 
 
Together these results show that the impairment of CNCCs to build up the chondro- 
skeletogenic elements starts earlier than the actual differentiation of the cells. The 
examinations of BA1 cells of control and Ezh2 cko embryos at E11.5 already shows 
the lack of early differentiation markers and effectors of the chondrogenic and 
skeletogenic lineages.  
Figure 36: Osteogenic markers are downregulated  
Q-RT-PCR revealed the significant downregulation of osteogenic markers in BA1 
cells of E11.5 Ezh2 cko embryos. Runx2 as key gene for osteogenic regulation, 
affects directly Osertix expression. Alkaline phosphatase is a later osteogenic 
marker. *P<0.05. 
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5.9 Transcriptome analysis on BA1 cells  
After checking the transition of MPCs  to osteoblasts and chondrogenic progenitors 
and finding first indications of chondro-/skeletogenic differentiation impairment, we 
decided to perform a microarray on BA1 cells to determine putative candidate genes 
that drive the phenotype in Ezh2 cko embryos.  
We performed an array on the Affymetrix A430 platform with 3 independent 
replicates for each genotype. The clustering of the replicates was consistent and 
comparable among the genotypes as shown by the heatmap of genes that are at 
least 2-fold up- or downregulated with a p-value <0.01 (Figure 37).  
 
 
 
 
 
 
 
Figure 37: Heatmap of 
microarray  
The microarray, using the 
Affymetrix A430 system 
showed a clustering of the 
genotypes. 3 independent 
samples of each 
genotype (Ezh2l/l and 
Ezh2l/l;Wnt1-Cre) were 
used.  
Z-Value is given color 
coded below the map.  
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Since Ezh2 mainly acts mainly as a repressor we first focused on the upregulated 
transcripts in Ezh2 cko BA1 cells with newly set parameters. Strikingly, many Hox 
gene transcripts were increased in Ezh2 cko BA1 cells, when we decreased the p-
value (p<0.001) to get highly significant differences as shown in Table 5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene symbol ratio p-value 
Hoxa9 134.3 1.43E-09 
Hoxa10 104.2 1.79E-11 
Hoxc8 56.2 3.12E-09 
Hoxb3 21.73 3.11E-08 
Hoxd13 21.47 1.01E-08 
Hoxc10 15.36 7.08E-06 
Hoxc4 12.12 4.17E-08 
Hoxa11 10.53 2.14E-06 
Hoxb13 10.2 4.03E-07 
Hoxa2 8.504 3.14E-08 
Hoxa5 4.95 0.0001511 
Hoxc9 4.338 1.78E-08 
Hoxa3 4.097 0.0001228 
Hoxc5 3.466 6.58E-06 
Hoxc13 2.592 2.73E-05 
Hoxd8 2.501 4.62E-05 
Hoxa1 2.355 1.21E-06 
Hoxb2 2.122 2.22E-05 
Hoxa7 2.089 6.43E-06 
Hoxb4 2.013 0.0001119 
Table 5: Hox gene overexpression in Ezh2 cko BA1 cells 
The micorarray showed a highly significant upregulation of many Hox genes. 
Normally, neural crest cells from the BA1 should be devoid of Hox gene expression. 
In Ezh2 cko BA1 cells almost all Hox genes get significantly upregulated when 
compared to control BA1 cells. The Hox genes underlayed with a green bar are 
known blockers of skeletogenesis.  
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The overexpression of Hox genes points again to the already described function of 
the PcG complexes to regulate Hox gene expression during embryonic 
development. Further the Hox genes are known repressors of skeletogenic 
differentiation in chicken (Couly, Grapin-Botton et al. 1998; Creuzet, Couly et al. 
2002), so we decided to focus on the 3 Hox genes described in these papers. The 3 
candidates are marked with the light green bar in Table 5, namely Hoxa2, Hoxa3 
and Hoxb4, with overexpression levels of 8.50-, 4.10- and 2.01-fold, respectively. All 
three genes were highly significant upregulated in the microarray when comparing 
BA1 cells from Ezh2 cko embryos with BA1 cells from control littermates (Table 5). 
To validate this we performed quantitative RT-PCR confirming the highly significant 
upregulation (p<0.001) of the 3 Hox genes that we selected. Hoxa2 was upregulated 
16.48 fold, for Hoxa3 there was an upregulation of 2.58 times observed and Hoxb4 
had a value of 6.51 times up when comparing Ezh2 cko BA1 to control BA1 cells in 
the quantitative RT-PCR (Figure 38).  
 
Figure 38: Hoxa2, Hoxa3 and Hoxb4 overexpression  
q-RT-PCR confirmed the highly significant upregulation of Hoxa2, Hoxa3 and Hoxb4 
in BA1 cells of Ezh2 cko embryos when compared to control embryos. ***P<0.001; 
±S.E.M. 
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5.10 H3K27me3 occupancy on Hoxa2, Hoxa3 and Hoxb4 transcriptional 
start sites in BA1 cells 
To exclude the possibility that Hoxa2, Hoxa3 and Hoxb4 get upregulated due to a 
secondary effect and are not a direct target of H3K27me3 in BA1 cells, we 
performed chromatin immunoprecipitation (ChIP) for H3K27me3 and checked the 
abundance of DNA with primers targeting the transcriptional start sites (TSS) of 
Hoxa2, Hoxa3 and Hoxb4 upon enrichment of chromatin with an antibody against 
H3K27me3. To control our results we used a positive control, Hoxd12 that should 
not be expressed in BA1 cells and compared the abundance of target gene DNA 
against abundance of a negative control, namely Hypoxanthine–Guanine 
Phosphoribosyltransferase (HPRT) a housekeeping gene that should be devoid of 
H3K27 trimethylation, since the H3K27me3 mark is found on silent gene promotors. 
 
 
 
 
 
 
 
 
 
 
Figure 39: ChIP analysis of Hoxa2, Hoxa3 and Hoxb4  
Chromatin immunoprecipitation proofed the H3K27me3 occupancy around 
transcriptional start sites of Hoxa2, Hoxa3 and Hoxb4 and therefore regulation of 
these genes by Ezh2 in BA1 cells. ±S.D. 
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As expected from the literature (Boyer, Plath et al. 2006), a study showing the 
occupancy of H3K27me3 on the Hox gene cluster in ESCs, all three genes (Hoxa2, 
Hoxa3 and Hoxb4) are target to H3K27me3 in wild-type BA1 cells as shown in 
Figure 39. These results demonstrate that the overexpression of Hoxa2, Hoxa3 and 
Hoxb4 in BA1 cells is due to the loss of H3K27me3 in Ezh2 cko embryos. And as 
already shown, these Hox genes are incompatible with skeletogenesis in CNCCs 
(Creuzet, Couly et al. 2002). This led us to the conclusion that we interfere with Hox 
gene expression, especially in the Hox negative domain (BA1 and rostrally). And 
especially in this domain the resulting overexpression of Hox genes is blocking the 
chondro- and skeletogenesis of CNCCs. Since CNCCs are the only subpopulation 
of NCCs which build up mesenchymal derivatives, the Hox gene overexpression has 
severe effects on the differentiation of CNCCs into skeletal elements of the 
craniofacial region.  
5.11 Downregulated genes from the microarray 
Table 6 shows transcripts that are highly significant downregulated in the microarray 
for at least 30%. Table 6 reveals the downregulation of ncRNA transcripts, like 
Dlx1as and Dlx6os1 and Dlx6os2. Further the table shows the already via 
immunohistochemistry shown downregulation of Collagens, like Col9a1 and Col2a1 
(Figure 35).  The collagens are thought to play a crucial role in chondrogenesis and 
it was already shown that Sox9 binds dirctly to the Col2a1 promoter (Bell, Leung et 
al. 1997). Further, transcripts of Sox5 and Sox6 are downregulated, as well. These 
genes have described roles in chondrogenesis, too (Yamashita, Miyaki et al. 2012). 
Another important gene family that was found to be downregulated in BA1 cells 
upon conditional knock-out of Ezh2 are the Dlx genes. These genes are known to 
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establish D-V axis in craniofacial development of BA cells, additionally to the A-P 
axis set up by Hox genes.  
 
 
 
Gene symbol ratio p-value 
Dlx1as 0.1378 6.09E-08 
Dlx6os1 0.3655 4.85E-06 
Dlx5 0.442 7.89E-07 
Sox5 0.4543 3.12E-05 
Msx2 0.4666 9.97E-06 
Msx1 0.4899 6.56E-05 
Dlx2 0.5101 1.96E-05 
Dlx6os2 0.5167 0.000251 
Sox5 0.5441 0.000629 
Dlx3 0.5801 4.40E-05 
Sox6 0.5803 0.000845 
Col9a1 0.5849 0.000231 
Dlx1 0.6309 5.15E-05 
Dlx4 0.6631 0.000224 
Col2a1 0.7064 0.000351 
Table 6: List of selected downregulated genes 
Some ncRNAs, Collagens, chondrogenic differentiation genes and many Dlx 
transcripts are highly significant downregulated in BA1 cells of ezh2 cko 
embryos when compared to control embryos. The Dlx genes are establishing 
the dorsal-ventral axis during mandibular development. 
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Figure 40: Dlx transcript downregulation upon Ezh2 loss in BA1 cells 
q-RT-PCR showed the downregulation of Dlx genes and ncRNAs (Dlx a/s and Dlx6 
os1) in Ezh2 cko BA1 cells when compared to control BA1 cells from E11.5 
embryos. This proofs the downregulation of genes which establish the dorso–ventral 
axis. Bars ± SEM 
5.12 Dlx genes downregulation  
The Hox genes might be crucial actors for the observed phenotype, but interestingly 
looking at highly significant downregulated genes in the microarray, we found many 
members of Dlx genes. The Dlx genes are a group of genes that establish the D-V 
patterning in BAs, additionally to the A-P axis that gets established by the Hox 
genes. Some Dlx genes are expressed along the D-V axis in BA1s and they show a 
nested expression, with declining expression levels towards distal (Kraus and Lufkin 
2006). The microarray (Table 6) revealed a highly significant downregulation of 
Dlx5/6 and Dlx1/2 that we confirmed with q-RT-PCR. Further the downregulation of 
antisense transcripts was confirmed. Dlx1 a/s and Dlx6 os1 are ncRNAs read out 
from the Dlx1 or Dlx6 locus, respectively.  
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6 Discussion 
6.1 General  
In my thesis we demonstrate that the PRC2 member Ezh2 is a key regulator of 
CNCC development and crucial for CNCCs to acquire a chondrogenic and 
osteogenic fate. Ezh2 conditional ablation and concomitant loss of Ezh2-mediated 
H3K27 trimethylation in the NC resulted in agenesis of all NC-derived craniofacial 
structures. Surprisingly, however, Ezh2 inactivation in the NC did not cause glial or 
neuronal defects in the PNS, indicating distinct requirements of epigenetic control 
mechanisms by different NC cell lineages. The only cells with NC origin capable of 
giving rise to skeletal elements of the face are located anterior to or in BA1 and BA2. 
Previously, it has been shown that the capacity of these cells for 
osteochondrogenesis is dependent on absence or downregulation of Hox gene 
expression (Minoux, Antonarakis et al. 2009). As shown here, conditional deletion of 
Ezh2 in NC led to strong upregulation and misexpression of multiple Hox genes in 
BA1 cells. Furthermore, we identified Hox genes as direct targets of H3K27me3 
dependent transcriptional repression in CNCCs. Thus, our findings reveal a crucial 
role of epigenetic gene silencing in regulating the formation of jaws and other 
craniofacial skeletal elements from NCCs.  
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6.2 Evolutionary aspects 
The NC evolved in a step wise fashion. First appearances in cephalochordates and 
ascidians of neural crest like cells (NCLC) point to this. The expression of some 
markers at the right time and location that will in vertebrates become the gene 
regulatory network for the NC was already found in ascidians and cephalochordates 
(Gostling and Shimeld 2003; Jeffery 2006). Clearly, the NC was indispensable for 
development of jaws, permitting a mobile, predatory lifestyle. Evolutionary, this was 
first seen in gnathans (Gans and Northcutt 1983). The gene regulatory networks for 
NC development are complex and some of the mechanisms that ended up in NCCs 
induction were duplicated from older mechanisms. An example would be jaw 
development. Emigrating from the dorsal tip of the neural tube CNCCs get induced 
and specified in the rhombomeres. The rhombomeres by themselves are 
segregated and highly dependent on the correct spatial patterning of the A-P axis 
via Hox genes. CNCCs overtake their “Hox-status” upon emigration from the neural 
tube and retain it when populating the BAs, but the Hox gene expression status is 
adjustable (Trainor and Krumlauf 2001; Alexander, Nolte et al. 2009). In areas 
where osteogenesis follows the intermediate step of BA development Hox gene 
expression has to be repressed. BA1 and FNP CNCCs develop in the skeletal 
elements of the jaws and therefore harbor already at these earlier stages the 
osteogenic and chondrogenic precursors. A crucial repressor of Hox genes in 
Drosophila development are the PcG genes, among them Ezh2. In Drosophila the 
only Hox cluster (Hox-C) is responsible for A-P patterning and the expression 
patterns of the respective Hox genes determining the positional identity on the A-P 
axis. The A-P axis positioning system is the same in mammalians and regulated by 
Hox genes and PcG genes, as well (Schuettengruber, Chourrout et al. 2007). 
Howevert, additional functions of Hox genes in mammalian development are again 
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regulated by PcG genes. An additional role for Hox genes (e.g. Hoxa2) in 
mammalian development is to be a hyoid fate chooser in BA2 during NC 
development (Kanzler, Kuschert et al. 1998). Moreover, Hox genes (e.g. Hoxa2, 
Hoxa3 and Hoxb4) are known repressors of skeletogenesis (Couly, Grapin-Botton et 
al. 1998; Creuzet, Couly et al. 2002). The Hox code in CNCCs that populate the 
BA1 and the FNP has to be repressed, since these structures have to be devoid of 
Hox gene expression to acquire their skeletal fate. This repression is again 
mediated by Ezh2 in mammalians as shown in this thesis. This could exemplify the 
“copying” of old systems to new functions. However, new regulatory elements have 
to evolve, a system directing the PRC complexes to silence the Hox gene 
expression in these cells again. The need of additional regulatory system of 
evolutionary conserved gene regulation systems might account for increasing 
amount of cis/trans regulatory elements in the genome during evolution (Sucena 
and Stern 2000; Trainor, Melton et al. 2003). Another possible regulation 
mechanism that might have evolved to control additional functions of already 
existing gene regulation systems could be ncRNAs. As shown in Figure 40 and 
Table 6, ncRNAs are downregulated in our Ezh2 cko BA1 cells. Dlx1 a/s and Dlx6 
os1 are antisense transcripts from the Dlx1 and Dlx6 loci that are downregulated, as 
well. It is not completely clear what functional role ncRNAs have but mostly they are 
considered to play a gene regulatory role and are counted as epigenetic mode 
(Figure 8). During evolution their number increases. It could reflect the additional 
need of regulatory elements when overtaking conventional protein-gene interactions 
(Qu and Adelson 2012). 
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6.3 Early events of NC development and PNS formation is not affected  
Early events of NC development including specification, migration and population of 
target structures could be a possible reason for the phenotype. After tracking NCCs 
with the R26R-LacZ reporter line it became obvious that NCCs expressing β-
galactosidase are present in the supposed structures, like BAs and DRG in control 
and Ezh2 cko embryos. Embryos with comparable patterns of X-Gal positive cells 
are seen until E11.5 (Figure 19 and Figure 20). Therefore we concluded that the 
early events of NC development are not affected upon conditional knock-out of 
Ezh2. And surprisingly, loss of Ezh2 in NCCs did also not affect formation of 
neurons and glia in peripheral ganglia and nerves (Figure 25 and Figure24). This is 
somewhat different to the situation in the CNS, where Ezh2 controls the choice 
between proliferation and neuronal differentiation, as well as the timely fate switch 
from neurogenesis to gliogenesis (Hirabayashi, Suzki et al. 2009; Pereira, Sansom 
et al. 2010). In contrast, DRG and AG of Ezh2 cko embryos contained normal 
numbers of sensory and autonomic neurons, respectively. Likewise, differentiation 
and timely appearance of satellite glia in ganglia and Schwann cells along peripheral 
nerves were not affected in Ezh2 cko animals when compared to control embryos. 
Taken together, the generation and differentiation of neural lineages from NC cells 
are apparently not dependent on Ezh2-mediated epigenetic gene regulation. 
Interestingly, Shen and colleagues have previously reported lineage-specific 
requirements for Ezh2 during differentiation of mouse ESCs. Ezh2 ablation in ESCs 
induced neural/ectoderm lineages at the expense of the mesodermal and 
endodermal differentiation programs. This suggests that the endodermal and 
mesodermal lineages are more susceptible to changes in Ezh2 activity than are 
neural lineages (Shen, Liu et al. 2008). Our findings are consistent with this 
hypothesis: Neural lineage formation remained unaffected upon inactivation of Ezh2 
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in the NC, whereas development of NC-derived mesenchymal progenitors, adopting 
a differentiation program similar to that of the mesoderm in vivo, was severely 
hampered in mutant mice.  
An alternative explanation for unimpaired PNS development in Ezh2 cko embryos is 
that in neural NC derivatives, Ezh1 activity might compensate for the loss of Ezh2 by 
catalyzing the methylation mark on H3K27, but fails to do so in cranial NC-derived 
MPCs. Others have previously demonstrated that upon loss of Ezh2, Ezh1 can 
overtake the catalytic function of Ezh2 for a particular subset of genes crucial for 
development (Boyer, Plath et al. 2006; Ezhkova, Lien et al. 2011). However, in the 
present study, conditional deletion of Ezh2 was accompanied by a major loss of 
H3K27me3 in all NC derivatives analyzed, including PNS structures, suggesting that 
Ezh1 was not able to assume Ezh2 functions in a global manner in mutant NCCs. 
Nonetheless, we cannot rule out that a subset of genes crucial for neurogenesis 
remain occupied by H3K27me3 in Ezh2 cko embryos due to Ezh1 compensation, 
allowing for normal PNS development. Furthermore, distinct epigenetic silencing 
mechanisms (e.g. H3K9 trimethylation and/or DNA methylation, in addition to H3K27 
trimethylation) might have redundant functions in repressing gene expression during 
PNS development. Conceivably, however, loss of Ezh2 and H3K27me3 leads to 
gene de-repression also in the PNS, but these genes encode factors that apparently 
do not interfere with neuronal and glial differentiation programs when 
overexpressed. 
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6.4 NCSC to MPC transition and cell cycle properties of MPCs 
During development, NCSCs originating in the cranial NC undergo a transition from 
NCSCs to MPCs, thereby losing neural potential and, at the same time, gaining the 
potential to produce mesenchymal lineages (John, Cinelli et al. 2011). This 
developmental switch is characterized by downregulation of the transcription factor 
Sox10 and concomitant upregulation of the transcription factor Sox 9. Sox9 has 
been implicated in craniofacial development (Mori-Akiyama, Akiyama et al. 2003), 
although its conditional ablation in the NC resulted in a much less severe phenotype 
than exhibited by Ezh2 cko embryos. One possible explanation for the craniofacial 
phenotype observed upon Ezh2 ablation may be failure of mutant NCSCs to give 
rise to MPCs. However, analysis of Sox9 and Sox10 expression levels did not reveal 
statistically significant changes upon Ezh2 inactivation (Figure 28). Therefore we 
assumed that this differentiation step from NCSCs to MPCs might not be the cause 
of the phenotype, but another feature of stem/progenitor cells is their self-renewal 
capacity so we checked the cell cycle properties of MPCs in BA1, since Ezh2 is a 
well described modulator of cell cycle progression (Chen, Bohrer et al. 2010; 
Kaneko, Li et al. 2010; Zeng, Chen et al. 2011) and controls maintenance and 
proliferation of a variety of stem cell types in normal tissue and cancer (Bracken, 
Dietrich et al. 2006; Ezhkova, Pasolli et al. 2009; Suva, Riggi et al. 2009; Pereira, 
Sansom et al. 2010; Juan, Derfoul et al. 2011; Herrera-Merchan, Arranz et al. 2012; 
McCabe, Graves et al. 2012; Qi, Chan et al. 2012). In contrast, the number of NCCs 
emigrating from the neural tube and localizing to NC target structures was not 
subject to Ezh2 dependent regulation. In fact, NC-specific Ezh2 ablation did not 
result in any changes in the cell cycle profile of NC-derived cells. These results 
indicate that the function of Ezh2 as a cell cycle modulator is tissue specific. 
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Moreover, our data reveal that Ezh2 exerts a major role in NCCs at relatively late 
stages of NC development, after NC specification and migration. 
6.5 Ezh2 is required for craniofacial chondro- and osteogenesis 
In contrast to NC specification, migration, population of target structures, PNS 
development and MPC establishment and cell cycle properties, Ezh2 activity is 
indispensable for osteochondrogenesis as already assumed from the observations 
of the phenotype at E12.5, E14.5 and E17.5 (Figure 21,Figure 22,Figure 23). Direct 
examinations on E14.5 and E17.5 Ezh2 cko embryos revealed the loss of almost all 
chondrogenic and skeletal elements that are derived from the NC (Figure 26 and 
Figure 27). Therefore one can assume that Ezh2 is crucial for the formation of the 
craniofacial skeletal elements originating from the NC. Not all skeletal elements are 
missing; this might be due to the NC specific knock-out of Ezh2 in NCCs affecting 
just the craniofacial elements derived from this cell population. Other reports 
showed the mixed origin of the cranial bones of vertebrates in lineage tracing 
studies. Derived from mesodermal and NCCs our phenotype just blocks the 
skeletogenesis of NC derived bones (Jiang, Iseki et al. 2002; Gross and Hanken 
2008). The first indications for the severe craniofacial phenotype are found already 
at early stages of chondrogenesis/skeletogenesis. E11.5 Ezh2 cko embryos were 
impaired in chondrogensis as indicated by the lack of Col2a1 in mutant BAs (Figure 
35). Additionally, other chondrogenic and osteogenic markers, such as Runx2, 
Osterix, and ALP, failed to be expressed by E11.5 BA1 cells upon Ezh2 deletion 
(Figure 36). Therefore one can conclude that Ezh2 inactivation prevents MPCs from 
acquiring an osteochondrogenic fate and, hence, producing cartilage and bone. 
 
 
 Discussion 
 
- 81 - 
 
6.6 Ezh2 activity silences Hox gene expression in CNCCs 
Craniofacial skeletal elements originating from the NC are exclusively produced 
from areas anterior to or located in BA1 and BA2, while NC cells posterior to these 
structures do not give rise to bone. Moreover, CNCCs that populate the BA1 and the 
FNP areas must have a Hox free ground pattern to undergo both forms of 
osteogenesis, endochondral and intramembranous ossification (Santagati and Rijli, 
2003; Kanzler et al., 1998). BA2 cells express a single Hox gene, namely Hoxa2, 
but certain cells from this area undergo endochondral ossification, becoming the 
inner ear bones, incus, stapes and malleus. The chondrogenic domain preceding 
the endochondral ossification of these bones, named Reichelt’s cartilage, is Hoxa2 
free (Kanzler, Kuschert et al. 1998; Santagati and Rijli 2003; Minoux, Antonarakis et 
al. 2009). NCCs more caudal to BA2 are characterized by expression of several Hox 
genes and display a well-defined Hox gene expression code that varies according to 
the A-P position. These Hox factors suppress osteochondrogenesis, hence 
restricting this potential to anterior NC populations. 
Large-scale analysis of ESCs has previously shown that Ezh2 occupancy, although 
widespread in the genome, is not global, but rather mostly associated with 
development related genes (Boyer et al., 2006). Among these, the Hox gene cluster 
turned out to be prominently regulated by Ezh2 in ESCs. Likewise, Hox genes are 
well-established targets of PcG regulation in Drosophila (Ringrose and Paro 2004; 
Sparmann and van Lohuizen 2006). Interestingly, our microarray analysis 
demonstrated that also in BA1 cells isolated from Ezh2 cko embryos at E11.5 many 
Hox genes are heavily upregulated when compared to E11.5 control embryos. 
Therefore, we concluded that massive Hox gene misexpression might be a major, 
but not exclusively, cause of the craniofacial defects observed upon conditional 
knock-out of Ezh2 and concomitant loss of H3K27me3 in NC cells.  
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Several reports have suggested that erratic Hox gene expression causes impaired 
chondrogenesis and osteogenesis. For instance, in chicken embryos, Hoxa2, highly 
overexpressed in BA1 cells of Ezh2 cko embryos is a well-known inhibitor of 
intramembranous bone formation from BAs (Couly, Grapin-Botton et al. 1998; 
Kanzler, Kuschert et al. 1998; Creuzet, Couly et al. 2002). Massip and colleagues 
have shown that ectopic expression of Hoxa2 in chondrocytes results in impaired 
differentiation, as demonstrated by the lack of Col2a1, and prevents cartilage 
formation (Massip, Ectors et al. 2007). In BA2, Hoxa2 is a promoter of the hyoid fate 
of mesenchymal CNCCs and restricts the chondrogenic domains that arise during 
endochondral ossification (Pasqualetti, Ori et al. 2000). Hoxa2 gain-of-function in 
BA1 cells results in a duplication of BA2 skeletal elements in Xenopus (Pasqualetti, 
Ori et al. 2000), whereas Hoxa2 loss in BA2 in mice leads to a mirror homeotic 
transformation of BA1 skeletal elements (Rijli, Mark et al. 1993). Importantly, Hoxa2 
in BA2 prevents osteogenesis by blocking its main effector Runx2. In addition, 
Hoxa2 is also involved in cartilage patterning until E11.5 by an independent 
mechanism that involves different cofactors. Conditional gene inactivation further 
revealed that subpopulations of CNCCs require Hoxa2 at defined time points for 
proper BA patterning (Santagati, Minoux et al. 2005). Hoxc8 is another factor that 
prevents endochondral differentiation by maintaining chondrocytes in a proliferative 
state and inhibiting chondrocyte hypertrophy (Yueh, Gardner et al. 1998). 
Furthermore, Hoxa9 is known to be a direct repressor of the earlier bone inducer 
osteopontin in lung epithelial cell lines (Shi, Bai et al. 2001). Finally, Hoxa3 and 
Hoxb4 are also well known inhibitors of osteogenesis in NC precursor cells. When 
individually overexpressed in NC derivatives of chicken embryos, Hoxa3 expression 
results in formation of rudimentary nasofrontal bud derivatives, whereas Hoxb4 
impairs terminal differentiation of BA1 derivatives such as the proximal bones 
(Couly, Grapin-Botton et al. 1998; Creuzet, Couly et al. 2002). However, when jointly 
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overexpressed, Hoxa3 and Hoxb4 block skeletogenesis to a similar extent than 
ectopic Hoxa2 expression.   
6.7 Dlx genes and D-V axis 
Additionally to the A-P axis specification of the Hox genes and their incompability 
with skeletogenesis, the Dlx genes determine the D-V axis in BAs.  Studies on mice 
showed that the loss of Dlx5/6 and Dlx1/2 resulted in jaw and skull malformations 
and the Dlx genes are described to play a role in endochondral ossification, 
especially Dlx5/6. Dlx genes are expressed in a nested fashion in BA1, Dlx1/2 
broadly and Dlx5/6 becoming progressively more distally restricted (Qiu, Bulfone et 
al. 1997; Acampora, Merlo et al. 1999; Depew, Lufkin et al. 2002; Kraus and Lufkin 
2006). Since agnathans express at least one Hox gene in the mandibular arch and 
gnathans do not and further the Dlx expression in the branchial arches is nested, 
these events were suspected to be critical steps in the evolution of jawed 
vertebrates (Cohn 2002; Trainor, Melton et al. 2003). Our microarray revealed a 
downregulation of Dlx genes (Figure 40; Table 6), additionally to the Hox gene 
overexpression (Table 5). Since we were conditionally knocking out Ezh2, a 
repressor of gene expression, the downregulation of Dlx genes is more likely a 
secondary effect. Possibly, the expression of Hox genes taken over by CNCCs from 
the rhombomeres might occur earlier leading to the assumption that these two gene 
effector cascades could influence each other. An assumption would be that 
expression of Hox genes in BA1 cells prevents the nested expression of Dlx genes 
that is necessary to establish the D-V axis in BA1 cells during jaw development. 
Disturbing the D-V axis position in BA1 cells results in a phenotype that partially 
resembles to a lesser extend the observed phenotype in our Ezh2 cko embryos. 
Therefore it is likely that the Dlx specification of the D-V axis could contribute to our 
phenotype. 
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6.8 Conclusion  
All these events indicate that NC precursors are specified for osteochondrogenesis 
in a temporally controlled manner, and that finely tuned regulation of Hox gene 
expression is crucial for this process. In BAs of Ezh2 cko embryos, high and ectopic 
expression of the Hox genes mentioned above to suppress osteo- and 
chondrogenesis (Hoxa2, Hoxa3, Hoxb4, Hoxa9, and Hoxc8), as well as of many 
other Hox genes, is associated with inhibition of chondrogenic and osteogenic gene 
expression programs and a virtually complete blockage of cartilage and bone 
formation from NCCs. In contrast, Ezh2 inactivation in NC does not affect neural 
lineage formation, which is in agreement with a previous study reporting undisturbed 
PNS development upon combined Hoxa2, Hoxa3 and Hoxb4 overexpression in 
CNCCs (Creuzet, Couly et al. 2002). Thus, Ezh2-mediated H3K27 trimethylation 
plays a lineage-specific role in NC cells, repressing Hox genes in anterior NC 
subpopulations and thus allowing osteochondrogenesis in these cells. Clearly, 
region-specific Hox gene regulation and the potential to form skeletal structures 
must involve other factors as well, given that Ezh2 and H3K27me3 are broadly 
expressed also in more posterior NC cells that in vivo do not form cartilage and 
bone. These factors include intrinsic cues distinguishing CNCCs from more caudal 
NC cells, as e.g. suggested by clonal assays in cell culture or by in vivo 
manipulation of signaling pathways regulating neural and osteochondrogenic fates, 
respectively (Buchmann-Moller, Miescher et al. 2009; Calloni, Le Douarin et al. 
2009; John, Cinelli et al. 2011). The nature of these cues and their potential 
functional interaction with epigenetic regulators including Ezh2 remains to be 
determined. Moreover, this study raises the intriguing question of whether and how 
epigenetic control of osteochondrogenesis in NCCs was implicated in the evolution 
of jawed vertebrates. 
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